# pathway_nodes

date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - ETANERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - ETANERCEPT - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £14,215
first_seen: 2022-09-14
last_seen: 2024-11-17
first_seen_parent: 2018-03-07
last_seen_parent: 2024-11-14
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 23 times with a 4.2 weekly interval (96.6 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 17 times with a 11.0 weekly interval (187.0 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 288.4, "avg_administrations": 10}, {"drug": "INFLIXIMAB", "avg_dose_mg": 255.5, "avg_administrations": 4}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - ETANERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - ETANERCEPT - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £10,098
first_seen: 2021-12-24
last_seen: 2024-02-23
first_seen_parent: 2020-09-09
last_seen_parent: 2024-11-05
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 9 times with a 3.9 weekly interval (35.1 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 11 times with a 8.5 weekly interval (93.5 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 365.7, "avg_administrations": 24}, {"drug": "NIVOLUMAB", "avg_dose_mg": 247.0, "avg_administrations": 30}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £7,498
first_seen: 2021-08-30
last_seen: 2024-11-24
first_seen_parent: 2019-09-08
last_seen_parent: 2025-01-23
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 301.5, "avg_administrations": 18}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 18 times with a 6.6 weekly interval (118.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - INFLIXIMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - INFLIXIMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £9,241
first_seen: 2020-08-13
last_seen: 2024-01-11
first_seen_parent: 2021-09-15
last_seen_parent: 2024-03-06
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: INFLIXIMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 12 times with a 7.8 weekly interval (93.6 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 18 times with a 12.0 weekly interval (216.0 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 310.5, "avg_administrations": 8}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 336.6, "avg_administrations": 10}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £22,736
first_seen: 2019-08-03
last_seen: 2024-06-21
first_seen_parent: 2017-02-21
last_seen_parent: 2024-12-19
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 134.9, "avg_administrations": 23}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 4 times with a 2.0 weekly interval (8.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - VEDOLIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - VEDOLIZUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £8,588
first_seen: 2021-06-05
last_seen: 2025-02-10
first_seen_parent: 2020-08-05
last_seen_parent: 2025-07-18
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: VEDOLIZUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 4 times with a 7.1 weekly interval (28.4 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 8 times with a 4.6 weekly interval (36.8 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 148.8, "avg_administrations": 10}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 265.3, "avg_administrations": 28}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - VEDOLIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - VEDOLIZUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £12,969
first_seen: 2020-03-09
last_seen: 2025-05-27
first_seen_parent: 2021-02-27
last_seen_parent: 2024-05-15
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: VEDOLIZUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 20 times with a 9.5 weekly interval (190.0 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 5 times with a 4.5 weekly interval (22.5 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 134.6, "avg_administrations": 29}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 123.4, "avg_administrations": 7}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £8,422
first_seen: 2019-06-22
last_seen: 2024-06-19
first_seen_parent: 2018-06-27
last_seen_parent: 2025-04-18
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 86.3, "avg_administrations": 16}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 23 times with a 4.1 weekly interval (94.3 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - TOFACITINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - TOFACITINIB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £14,831
first_seen: 2020-09-21
last_seen: 2025-07-09
first_seen_parent: 2019-07-29
last_seen_parent: 2024-12-20
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TOFACITINIB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 14 times with a 10.6 weekly interval (148.4 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 11 times with a 9.7 weekly interval (106.7 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 225.3, "avg_administrations": 22}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 490.0, "avg_administrations": 10}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £15,296
first_seen: 2021-11-04
last_seen: 2024-02-28
first_seen_parent: 2019-01-16
last_seen_parent: 2024-05-04
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 371.1, "avg_administrations": 16}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 17 times with a 5.0 weekly interval (85.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - AFLIBERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - AFLIBERCEPT - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £9,368
first_seen: 2019-08-15
last_seen: 2024-08-01
first_seen_parent: 2020-08-03
last_seen_parent: 2025-10-08
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: AFLIBERCEPT|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 4 times with a 10.6 weekly interval (42.4 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 18 times with a 11.2 weekly interval (201.6 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 169.1, "avg_administrations": 14}, {"drug": "RITUXIMAB", "avg_dose_mg": 426.3, "avg_administrations": 14}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £23,286
first_seen: 2019-02-08
last_seen: 2024-11-18
first_seen_parent: 2017-02-22
last_seen_parent: 2024-06-30
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 173.9, "avg_administrations": 28}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 13 times with a 11.5 weekly interval (149.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £20,769
first_seen: 2021-12-23
last_seen: 2024-12-05
first_seen_parent: 2019-09-13
last_seen_parent: 2025-07-31
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 396.3, "avg_administrations": 16}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 13 times with a 8.1 weekly interval (105.3 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £15,013
first_seen: 2021-05-17
last_seen: 2025-01-15
first_seen_parent: 2018-05-10
last_seen_parent: 2025-01-19
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 78.1, "avg_administrations": 21}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 6 times with a 4.9 weekly interval (29.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - BARICITINIB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - BARICITINIB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £6,865
first_seen: 2019-06-21
last_seen: 2025-10-08
first_seen_parent: 2021-11-10
last_seen_parent: 2025-06-22
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: BARICITINIB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 9 times with a 9.3 weekly interval (83.7 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 8 times with a 9.7 weekly interval (77.6 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 201.8, "avg_administrations": 9}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 445.4, "avg_administrations": 21}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £17,136
first_seen: 2021-08-26
last_seen: 2025-11-04
first_seen_parent: 2020-07-13
last_seen_parent: 2024-07-24
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 244.1, "avg_administrations": 14}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 22 times with a 9.1 weekly interval (200.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - ADALIMUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - ADALIMUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £11,145
first_seen: 2019-11-23
last_seen: 2025-03-05
first_seen_parent: 2019-04-23
last_seen_parent: 2024-11-22
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 16 times with a 10.1 weekly interval (161.6 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 19 times with a 8.9 weekly interval (169.1 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 375.2, "avg_administrations": 21}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 356.8, "avg_administrations": 24}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £5,520
first_seen: 2020-12-11
last_seen: 2025-07-09
first_seen_parent: 2018-08-14
last_seen_parent: 2025-06-15
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 295.2, "avg_administrations": 10}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 25 times with a 7.9 weekly interval (197.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - USTEKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - USTEKINUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £21,515
first_seen: 2021-04-05
last_seen: 2025-06-16
first_seen_parent: 2018-05-05
last_seen_parent: 2025-03-03
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 19 times with a 2.3 weekly interval (43.7 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 13 times with a 2.2 weekly interval (28.6 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 256.6, "avg_administrations": 21}, {"drug": "RITUXIMAB", "avg_dose_mg": 172.1, "avg_administrations": 12}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £14,706
first_seen: 2018-09-07
last_seen: 2025-01-13
first_seen_parent: 2020-09-03
last_seen_parent: 2025-09-02
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 282.6, "avg_administrations": 17}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 25 times with a 4.6 weekly interval (115.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £9,004
first_seen: 2018-06-15
last_seen: 2024-08-29
first_seen_parent: 2018-01-10
last_seen_parent: 2024-11-07
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 95.7, "avg_administrations": 25}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 27 times with a 10.3 weekly interval (278.1 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - USTEKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - USTEKINUMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £18,011
first_seen: 2022-10-28
last_seen: 2025-03-19
first_seen_parent: 2019-01-28
last_seen_parent: 2024-04-04
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 15 times with a 7.1 weekly interval (106.5 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 17 times with a 9.8 weekly interval (166.6 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 497.3, "avg_administrations": 19}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 256.0, "avg_administrations": 14}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - USTEKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - USTEKINUMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £9,372
first_seen: 2019-06-13
last_seen: 2024-10-19
first_seen_parent: 2018-11-25
last_seen_parent: 2025-11-26
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 19 times with a 9.1 weekly interval (172.9 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 25 times with a 2.9 weekly interval (72.5 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 285.8, "avg_administrations": 23}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 300.7, "avg_administrations": 21}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £17,251
first_seen: 2021-03-12
last_seen: 2024-03-05
first_seen_parent: 2019-07-04
last_seen_parent: 2025-01-13
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 210.8, "avg_administrations": 21}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 16 times with a 10.5 weekly interval (168.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - ADALIMUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - ADALIMUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £9,103
first_seen: 2022-09-05
last_seen: 2025-01-31
first_seen_parent: 2019-02-26
last_seen_parent: 2025-03-29
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 14 times with a 11.8 weekly interval (165.2 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 30 times with a 11.2 weekly interval (336.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 101.5, "avg_administrations": 6}, {"drug": "ETANERCEPT", "avg_dose_mg": 107.2, "avg_administrations": 5}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £22,526
first_seen: 2020-06-28
last_seen: 2024-03-15
first_seen_parent: 2020-09-02
last_seen_parent: 2025-04-29
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 152.2, "avg_administrations": 16}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4 times with a 10.2 weekly interval (40.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £25,696
first_seen: 2021-03-10
last_seen: 2024-03-20
first_seen_parent: 2019-07-27
last_seen_parent: 2025-01-04
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 444.4, "avg_administrations": 12}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 27 times with a 6.5 weekly interval (175.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - RITUXIMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £11,620
first_seen: 2020-04-30
last_seen: 2024-05-01
first_seen_parent: 2019-08-11
last_seen_parent: 2024-11-05
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 27 times with a 7.0 weekly interval (189.0 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 12 times with a 6.4 weekly interval (76.8 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 375.8, "avg_administrations": 4}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 461.1, "avg_administrations": 6}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - RITUXIMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £14,173
first_seen: 2022-02-20
last_seen: 2024-11-01
first_seen_parent: 2021-02-16
last_seen_parent: 2024-08-17
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 5 times with a 7.4 weekly interval (37.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 4 times with a 5.3 weekly interval (21.2 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 387.1, "avg_administrations": 26}, {"drug": "USTEKINUMAB", "avg_dose_mg": 144.6, "avg_administrations": 18}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £11,068
first_seen: 2018-07-31
last_seen: 2024-03-31
first_seen_parent: 2018-08-25
last_seen_parent: 2024-01-17
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 86.9, "avg_administrations": 14}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 15 times with a 5.0 weekly interval (75.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £17,278
first_seen: 2018-07-07
last_seen: 2024-02-09
first_seen_parent: 2019-07-10
last_seen_parent: 2025-03-25
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 400.3, "avg_administrations": 10}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 6 times with a 3.8 weekly interval (22.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - LENALIDOMIDE
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - LENALIDOMIDE - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £8,298
first_seen: 2019-01-13
last_seen: 2024-12-20
first_seen_parent: 2020-03-24
last_seen_parent: 2024-12-20
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 17 times with a 7.0 weekly interval (119.0 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 19 times with a 7.9 weekly interval (150.1 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 105.1, "avg_administrations": 9}, {"drug": "BARICITINIB", "avg_dose_mg": 276.9, "avg_administrations": 12}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - LENALIDOMIDE
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - LENALIDOMIDE - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £17,778
first_seen: 2022-11-25
last_seen: 2024-10-21
first_seen_parent: 2019-06-18
last_seen_parent: 2024-06-20
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 27 times with a 8.4 weekly interval (226.8 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 13 times with a 7.0 weekly interval (91.0 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 96.8, "avg_administrations": 10}, {"drug": "NATALIZUMAB", "avg_dose_mg": 210.4, "avg_administrations": 5}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £3,541
first_seen: 2018-01-25
last_seen: 2024-04-30
first_seen_parent: 2017-07-14
last_seen_parent: 2025-06-28
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 225.7, "avg_administrations": 14}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 23 times with a 10.4 weekly interval (239.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - OCRELIZUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £16,002
first_seen: 2020-11-29
last_seen: 2024-09-18
first_seen_parent: 2020-07-25
last_seen_parent: 2024-11-30
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 9 times with a 8.4 weekly interval (75.6 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 12 times with a 8.3 weekly interval (99.6 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 313.3, "avg_administrations": 17}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 473.9, "avg_administrations": 19}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - OCRELIZUMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £16,724
first_seen: 2019-11-08
last_seen: 2025-08-14
first_seen_parent: 2021-03-24
last_seen_parent: 2025-07-07
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 27 times with a 6.5 weekly interval (175.5 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 24 times with a 6.3 weekly interval (151.2 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 272.7, "avg_administrations": 27}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 75.5, "avg_administrations": 21}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £14,475
first_seen: 2020-11-03
last_seen: 2025-12-19
first_seen_parent: 2018-03-22
last_seen_parent: 2025-01-11
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 319.9, "avg_administrations": 13}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 18 times with a 8.9 weekly interval (160.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £11,127
first_seen: 2021-12-05
last_seen: 2024-07-13
first_seen_parent: 2018-08-09
last_seen_parent: 2025-10-04
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 338.2, "avg_administrations": 6}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 29 times with a 2.8 weekly interval (81.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £7,476
first_seen: 2020-01-06
last_seen: 2025-02-09
first_seen_parent: 2019-08-26
last_seen_parent: 2025-04-30
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 247.7, "avg_administrations": 7}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 19 times with a 8.2 weekly interval (155.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £11,951
first_seen: 2021-07-12
last_seen: 2025-04-08
first_seen_parent: 2018-09-28
last_seen_parent: 2024-06-09
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 268.3, "avg_administrations": 17}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 5 times with a 5.1 weekly interval (25.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - NIVOLUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - NIVOLUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £16,717
first_seen: 2019-02-02
last_seen: 2025-09-23
first_seen_parent: 2020-01-22
last_seen_parent: 2025-04-20
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: NIVOLUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 20 times with a 8.1 weekly interval (162.0 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 9 times with a 2.2 weekly interval (19.8 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 108.5, "avg_administrations": 10}, {"drug": "NATALIZUMAB", "avg_dose_mg": 192.5, "avg_administrations": 15}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - NIVOLUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - NIVOLUMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £10,780
first_seen: 2020-12-06
last_seen: 2025-07-19
first_seen_parent: 2018-06-14
last_seen_parent: 2025-06-30
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: NIVOLUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 4 times with a 5.4 weekly interval (21.6 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 9 times with a 10.3 weekly interval (92.7 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 152.4, "avg_administrations": 8}, {"drug": "ADALIMUMAB", "avg_dose_mg": 436.8, "avg_administrations": 7}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £6,693
first_seen: 2021-05-02
last_seen: 2024-04-03
first_seen_parent: 2019-04-01
last_seen_parent: 2024-09-19
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 279.4, "avg_administrations": 23}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 23 times with a 4.6 weekly interval (105.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £16,239
first_seen: 2021-04-05
last_seen: 2024-11-26
first_seen_parent: 2020-10-12
last_seen_parent: 2024-08-04
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 68.9, "avg_administrations": 14}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7 times with a 11.2 weekly interval (78.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £18,898
first_seen: 2019-11-20
last_seen: 2024-05-03
first_seen_parent: 2020-12-25
last_seen_parent: 2024-03-26
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 102.0, "avg_administrations": 28}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 11 times with a 8.6 weekly interval (94.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - RANIBIZUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £14,132
first_seen: 2022-09-10
last_seen: 2024-09-07
first_seen_parent: 2018-12-02
last_seen_parent: 2024-05-15
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 20 times with a 5.7 weekly interval (114.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 20 times with a 10.5 weekly interval (210.0 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 226.5, "avg_administrations": 26}, {"drug": "USTEKINUMAB", "avg_dose_mg": 428.2, "avg_administrations": 28}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - RANIBIZUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £9,410
first_seen: 2020-11-03
last_seen: 2024-08-10
first_seen_parent: 2018-12-10
last_seen_parent: 2025-08-29
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4 times with a 2.6 weekly interval (10.4 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 27 times with a 4.2 weekly interval (113.4 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 81.8, "avg_administrations": 15}, {"drug": "ETANERCEPT", "avg_dose_mg": 376.9, "avg_administrations": 4}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £25,993
first_seen: 2021-06-30
last_seen: 2024-07-08
first_seen_parent: 2019-11-13
last_seen_parent: 2025-11-14
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 177.8, "avg_administrations": 13}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 21 times with a 10.9 weekly interval (228.9 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £19,605
first_seen: 2021-02-25
last_seen: 2025-01-09
first_seen_parent: 2017-05-30
last_seen_parent: 2024-11-10
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 196.1, "avg_administrations": 22}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 20 times with a 7.6 weekly interval (152.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £3,102
first_seen: 2021-08-23
last_seen: 2025-06-16
first_seen_parent: 2017-02-09
last_seen_parent: 2024-01-11
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 176.3, "avg_administrations": 20}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: RHEUMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 8 times with a 3.5 weekly interval (28.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ETANERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ETANERCEPT - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £11,041
first_seen: 2020-10-05
last_seen: 2025-02-21
first_seen_parent: 2020-12-20
last_seen_parent: 2025-12-09
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ETANERCEPT|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 21 times with a 11.9 weekly interval (249.9 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 13 times with a 2.8 weekly interval (36.4 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 57.8, "avg_administrations": 18}, {"drug": "RITUXIMAB", "avg_dose_mg": 359.1, "avg_administrations": 4}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £19,632
first_seen: 2018-11-19
last_seen: 2024-10-13
first_seen_parent: 2020-07-24
last_seen_parent: 2024-05-18
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 474.5, "avg_administrations": 14}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 16 times with a 9.1 weekly interval (145.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - BARICITINIB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - BARICITINIB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £11,460
first_seen: 2021-09-06
last_seen: 2025-04-25
first_seen_parent: 2021-05-20
last_seen_parent: 2025-06-26
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: BARICITINIB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 28 times with a 6.5 weekly interval (182.0 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 24 times with a 9.5 weekly interval (228.0 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 483.7, "avg_administrations": 17}, {"drug": "NATALIZUMAB", "avg_dose_mg": 432.7, "avg_administrations": 16}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £21,962
first_seen: 2018-11-03
last_seen: 2024-08-15
first_seen_parent: 2019-04-26
last_seen_parent: 2024-03-08
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 190.1, "avg_administrations": 15}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 14 times with a 2.0 weekly interval (28.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £24,819
first_seen: 2018-12-03
last_seen: 2024-02-09
first_seen_parent: 2019-08-06
last_seen_parent: 2025-04-04
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 489.7, "avg_administrations": 13}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 22 times with a 7.5 weekly interval (165.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £5,315
first_seen: 2018-11-11
last_seen: 2025-11-01
first_seen_parent: 2020-09-20
last_seen_parent: 2024-08-05
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 139.5, "avg_administrations": 7}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 5 times with a 7.3 weekly interval (36.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £10,343
first_seen: 2020-05-12
last_seen: 2025-12-17
first_seen_parent: 2017-06-16
last_seen_parent: 2025-03-03
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 495.2, "avg_administrations": 12}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 18 times with a 2.3 weekly interval (41.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - RITUXIMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £13,541
first_seen: 2022-12-06
last_seen: 2025-02-21
first_seen_parent: 2018-11-30
last_seen_parent: 2024-10-17
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 29 times with a 7.7 weekly interval (223.3 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 9 times with a 8.1 weekly interval (72.9 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 301.9, "avg_administrations": 21}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 143.4, "avg_administrations": 19}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - RITUXIMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £10,717
first_seen: 2019-08-30
last_seen: 2025-10-05
first_seen_parent: 2021-06-16
last_seen_parent: 2025-06-21
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 24 times with a 4.6 weekly interval (110.4 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 12 times with a 5.9 weekly interval (70.8 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 290.0, "avg_administrations": 18}, {"drug": "SECUKINUMAB", "avg_dose_mg": 72.2, "avg_administrations": 5}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £20,346
first_seen: 2020-03-04
last_seen: 2025-09-13
first_seen_parent: 2018-10-22
last_seen_parent: 2025-08-28
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 51.5, "avg_administrations": 27}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 28 times with a 5.2 weekly interval (145.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £14,367
first_seen: 2018-05-13
last_seen: 2024-11-30
first_seen_parent: 2019-09-11
last_seen_parent: 2024-04-27
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 446.8, "avg_administrations": 14}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 30 times with a 8.6 weekly interval (258.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £6,960
first_seen: 2020-08-27
last_seen: 2024-02-24
first_seen_parent: 2017-12-01
last_seen_parent: 2025-10-15
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 294.4, "avg_administrations": 15}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 21 times with a 6.7 weekly interval (140.7 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - OCRELIZUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £8,451
first_seen: 2022-06-16
last_seen: 2024-01-15
first_seen_parent: 2019-08-22
last_seen_parent: 2024-06-09
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 17 times with a 5.4 weekly interval (91.8 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 24 times with a 10.7 weekly interval (256.8 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 284.9, "avg_administrations": 13}, {"drug": "IBRUTINIB", "avg_dose_mg": 132.0, "avg_administrations": 14}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - OCRELIZUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £10,388
first_seen: 2021-02-15
last_seen: 2025-09-17
first_seen_parent: 2020-06-27
last_seen_parent: 2024-05-11
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 30 times with a 2.6 weekly interval (78.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 25 times with a 7.8 weekly interval (195.0 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 338.7, "avg_administrations": 14}, {"drug": "ETANERCEPT", "avg_dose_mg": 79.4, "avg_administrations": 24}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £6,581
first_seen: 2018-09-05
last_seen: 2024-12-27
first_seen_parent: 2020-05-18
last_seen_parent: 2025-01-16
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 356.4, "avg_administrations": 20}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 15 times with a 7.7 weekly interval (115.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £15,319
first_seen: 2020-08-18
last_seen: 2025-10-06
first_seen_parent: 2017-03-30
last_seen_parent: 2024-01-17
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 439.9, "avg_administrations": 15}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 7 times with a 5.7 weekly interval (39.9 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - PEMBROLIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - PEMBROLIZUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £11,153
first_seen: 2020-08-13
last_seen: 2025-10-01
first_seen_parent: 2018-07-20
last_seen_parent: 2025-12-25
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 18 times with a 5.1 weekly interval (91.8 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 24 times with a 2.1 weekly interval (50.4 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 432.2, "avg_administrations": 27}, {"drug": "SECUKINUMAB", "avg_dose_mg": 294.2, "avg_administrations": 8}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £9,638
first_seen: 2018-08-01
last_seen: 2025-05-04
first_seen_parent: 2020-08-29
last_seen_parent: 2024-02-17
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 461.2, "avg_administrations": 15}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 24 times with a 4.7 weekly interval (112.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £10,955
first_seen: 2021-11-23
last_seen: 2024-10-05
first_seen_parent: 2019-04-29
last_seen_parent: 2024-12-11
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 407.7, "avg_administrations": 18}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: ONCOLOGY
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 4 times with a 2.9 weekly interval (11.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £8,903
first_seen: 2019-02-07
last_seen: 2024-11-30
first_seen_parent: 2018-11-19
last_seen_parent: 2025-05-29
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 104.8, "avg_administrations": 24}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 29 times with a 10.3 weekly interval (298.7 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £12,405
first_seen: 2022-12-04
last_seen: 2024-08-31
first_seen_parent: 2020-03-23
last_seen_parent: 2024-05-31
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 26 times with a 9.5 weekly interval (247.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 10 times with a 10.4 weekly interval (104.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 184.2, "avg_administrations": 4}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 337.0, "avg_administrations": 10}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £6,806
first_seen: 2019-05-14
last_seen: 2024-04-19
first_seen_parent: 2020-02-18
last_seen_parent: 2024-08-12
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 319.8, "avg_administrations": 28}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 19 times with a 7.1 weekly interval (134.9 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £21,576
first_seen: 2018-03-03
last_seen: 2025-08-29
first_seen_parent: 2020-05-18
last_seen_parent: 2024-08-07
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 415.7, "avg_administrations": 30}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 27 times with a 6.6 weekly interval (178.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - TOFACITINIB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - TOFACITINIB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £14,106
first_seen: 2022-08-01
last_seen: 2025-10-16
first_seen_parent: 2021-07-31
last_seen_parent: 2025-05-25
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: TOFACITINIB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 14 times with a 5.2 weekly interval (72.8 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 12 times with a 2.5 weekly interval (30.0 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 128.8, "avg_administrations": 22}, {"drug": "ADALIMUMAB", "avg_dose_mg": 126.6, "avg_administrations": 9}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - TOFACITINIB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - TOFACITINIB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £6,939
first_seen: 2022-09-18
last_seen: 2025-06-16
first_seen_parent: 2020-10-24
last_seen_parent: 2024-04-02
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: TOFACITINIB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 22 times with a 7.5 weekly interval (165.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 21 times with a 3.9 weekly interval (81.9 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 498.6, "avg_administrations": 12}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 246.7, "avg_administrations": 15}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £13,193
first_seen: 2021-07-02
last_seen: 2024-07-14
first_seen_parent: 2019-12-11
last_seen_parent: 2024-07-18
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 481.0, "avg_administrations": 29}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 26 times with a 11.7 weekly interval (304.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £5,707
first_seen: 2019-02-28
last_seen: 2024-03-09
first_seen_parent: 2018-02-03
last_seen_parent: 2025-02-02
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 373.2, "avg_administrations": 9}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 28 times with a 4.7 weekly interval (131.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £5,018
first_seen: 2018-10-29
last_seen: 2024-05-12
first_seen_parent: 2020-12-04
last_seen_parent: 2025-02-03
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 115.4, "avg_administrations": 21}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 24 times with a 2.4 weekly interval (57.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £19,352
first_seen: 2021-06-10
last_seen: 2024-10-23
first_seen_parent: 2017-08-03
last_seen_parent: 2024-03-01
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 463.2, "avg_administrations": 6}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 11 times with a 4.4 weekly interval (48.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £6,199
first_seen: 2021-02-01
last_seen: 2025-03-12
first_seen_parent: 2018-05-18
last_seen_parent: 2025-11-26
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 168.6, "avg_administrations": 20}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 21 times with a 10.1 weekly interval (212.1 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £8,585
first_seen: 2021-08-02
last_seen: 2025-12-09
first_seen_parent: 2020-04-15
last_seen_parent: 2025-12-12
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 421.4, "avg_administrations": 18}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 14 times with a 3.8 weekly interval (53.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - INFLIXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - INFLIXIMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £5,111
first_seen: 2020-02-09
last_seen: 2025-10-13
first_seen_parent: 2018-12-24
last_seen_parent: 2025-03-02
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 9 times with a 6.2 weekly interval (55.8 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 16 times with a 3.4 weekly interval (54.4 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 398.2, "avg_administrations": 20}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 104.9, "avg_administrations": 13}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - INFLIXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - INFLIXIMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £8,199
first_seen: 2022-07-09
last_seen: 2025-01-26
first_seen_parent: 2018-06-11
last_seen_parent: 2025-11-03
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 17 times with a 5.4 weekly interval (91.8 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 25 times with a 2.4 weekly interval (60.0 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 400.2, "avg_administrations": 22}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 104.3, "avg_administrations": 7}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £5,617
first_seen: 2020-01-05
last_seen: 2024-08-28
first_seen_parent: 2018-09-23
last_seen_parent: 2024-10-22
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 319.3, "avg_administrations": 22}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 29 times with a 5.4 weekly interval (156.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £10,849
first_seen: 2021-09-12
last_seen: 2024-06-23
first_seen_parent: 2019-10-09
last_seen_parent: 2024-10-26
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 420.1, "avg_administrations": 24}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 22 times with a 11.0 weekly interval (242.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £14,594
first_seen: 2021-02-21
last_seen: 2025-01-15
first_seen_parent: 2019-08-14
last_seen_parent: 2025-02-15
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 4 times with a 4.3 weekly interval (17.2 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 11 times with a 6.1 weekly interval (67.1 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 91.2, "avg_administrations": 13}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 269.9, "avg_administrations": 22}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £16,182
first_seen: 2020-03-28
last_seen: 2024-05-21
first_seen_parent: 2020-02-19
last_seen_parent: 2024-03-24
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 19 times with a 10.8 weekly interval (205.2 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 23 times with a 4.8 weekly interval (110.4 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 208.2, "avg_administrations": 16}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 438.9, "avg_administrations": 9}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £16,888
first_seen: 2021-10-07
last_seen: 2024-02-28
first_seen_parent: 2020-12-09
last_seen_parent: 2025-07-26
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 352.8, "avg_administrations": 29}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 20 times with a 8.9 weekly interval (178.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £6,722
first_seen: 2020-06-14
last_seen: 2024-08-03
first_seen_parent: 2019-11-24
last_seen_parent: 2024-10-16
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 107.9, "avg_administrations": 26}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 25 times with a 5.7 weekly interval (142.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £27,530
first_seen: 2019-05-06
last_seen: 2024-05-28
first_seen_parent: 2020-10-16
last_seen_parent: 2025-05-28
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 116.3, "avg_administrations": 12}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 14 times with a 11.6 weekly interval (162.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £23,092
first_seen: 2018-10-06
last_seen: 2024-07-01
first_seen_parent: 2017-08-25
last_seen_parent: 2025-03-26
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 349.2, "avg_administrations": 22}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 24 times with a 9.8 weekly interval (235.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - IBRUTINIB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £12,345
first_seen: 2021-01-25
last_seen: 2024-03-19
first_seen_parent: 2020-06-11
last_seen_parent: 2025-11-26
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 4 times with a 8.9 weekly interval (35.6 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 13 times with a 2.2 weekly interval (28.6 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 484.8, "avg_administrations": 9}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 415.1, "avg_administrations": 23}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - IBRUTINIB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £4,410
first_seen: 2022-10-30
last_seen: 2024-04-22
first_seen_parent: 2019-07-24
last_seen_parent: 2025-01-27
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 11 times with a 2.6 weekly interval (28.6 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 12 times with a 3.4 weekly interval (40.8 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 171.6, "avg_administrations": 6}, {"drug": "ADALIMUMAB", "avg_dose_mg": 428.6, "avg_administrations": 4}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £13,766
first_seen: 2021-09-16
last_seen: 2025-08-11
first_seen_parent: 2017-02-25
last_seen_parent: 2024-07-01
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 497.0, "avg_administrations": 26}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 21 times with a 2.1 weekly interval (44.1 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £17,962
first_seen: 2021-08-06
last_seen: 2024-01-10
first_seen_parent: 2017-02-23
last_seen_parent: 2025-09-03
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 231.1, "avg_administrations": 10}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 26 times with a 2.7 weekly interval (70.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £17,519
first_seen: 2020-02-25
last_seen: 2024-01-03
first_seen_parent: 2019-07-07
last_seen_parent: 2025-05-17
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 203.6, "avg_administrations": 15}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 24 times with a 10.5 weekly interval (252.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - NATALIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - NATALIZUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £4,848
first_seen: 2020-02-08
last_seen: 2025-04-21
first_seen_parent: 2021-05-22
last_seen_parent: 2024-07-24
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 14 times with a 7.9 weekly interval (110.6 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 12 times with a 8.0 weekly interval (96.0 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 218.8, "avg_administrations": 16}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 143.0, "avg_administrations": 24}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - NATALIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - NATALIZUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £5,736
first_seen: 2021-05-19
last_seen: 2025-09-06
first_seen_parent: 2018-05-02
last_seen_parent: 2024-05-21
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 12 times with a 5.5 weekly interval (66.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 20 times with a 2.9 weekly interval (58.0 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 349.1, "avg_administrations": 22}, {"drug": "INFLIXIMAB", "avg_dose_mg": 158.2, "avg_administrations": 16}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £8,137
first_seen: 2020-03-15
last_seen: 2024-03-28
first_seen_parent: 2020-02-18
last_seen_parent: 2025-06-14
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 247.9, "avg_administrations": 17}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 12 times with a 7.9 weekly interval (94.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £22,680
first_seen: 2019-08-03
last_seen: 2024-06-12
first_seen_parent: 2017-06-19
last_seen_parent: 2025-01-31
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 221.7, "avg_administrations": 16}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 30 times with a 4.7 weekly interval (141.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £17,269
first_seen: 2020-05-01
last_seen: 2025-02-13
first_seen_parent: 2020-11-26
last_seen_parent: 2024-05-10
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 113.4, "avg_administrations": 18}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 11 times with a 2.0 weekly interval (22.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - TRASTUZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - TRASTUZUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £3,895
first_seen: 2022-12-01
last_seen: 2025-09-09
first_seen_parent: 2021-06-21
last_seen_parent: 2024-07-08
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 28 times with a 2.5 weekly interval (70.0 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 9 times with a 10.3 weekly interval (92.7 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 419.6, "avg_administrations": 16}, {"drug": "NATALIZUMAB", "avg_dose_mg": 201.3, "avg_administrations": 24}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - TRASTUZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - TRASTUZUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £20,075
first_seen: 2022-12-17
last_seen: 2025-12-17
first_seen_parent: 2021-08-26
last_seen_parent: 2025-03-21
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 9 times with a 2.5 weekly interval (22.5 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 15 times with a 11.6 weekly interval (174.0 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 425.3, "avg_administrations": 20}, {"drug": "INFLIXIMAB", "avg_dose_mg": 226.0, "avg_administrations": 17}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £12,211
first_seen: 2021-10-22
last_seen: 2025-05-04
first_seen_parent: 2020-11-02
last_seen_parent: 2024-03-18
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 56.0, "avg_administrations": 21}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 23 times with a 11.1 weekly interval (255.3 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £13,336
first_seen: 2019-09-23
last_seen: 2025-03-07
first_seen_parent: 2018-10-17
last_seen_parent: 2024-05-07
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 364.9, "avg_administrations": 12}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 12 times with a 2.0 weekly interval (24.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £6,344
first_seen: 2018-04-05
last_seen: 2024-09-28
first_seen_parent: 2019-12-13
last_seen_parent: 2025-11-20
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 316.0, "avg_administrations": 11}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 30 times with a 10.1 weekly interval (303.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £8,950
first_seen: 2018-11-19
last_seen: 2025-11-19
first_seen_parent: 2017-05-22
last_seen_parent: 2025-03-19
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 331.4, "avg_administrations": 23}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 23 times with a 9.8 weekly interval (225.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - ADALIMUMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £16,365
first_seen: 2019-06-17
last_seen: 2025-02-08
first_seen_parent: 2021-11-13
last_seen_parent: 2024-11-27
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 15 times with a 6.6 weekly interval (99.0 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 17 times with a 6.5 weekly interval (110.5 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 394.6, "avg_administrations": 8}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 59.3, "avg_administrations": 25}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - ADALIMUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £3,544
first_seen: 2021-08-26
last_seen: 2025-12-15
first_seen_parent: 2019-04-29
last_seen_parent: 2025-07-14
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 25 times with a 2.3 weekly interval (57.5 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 18 times with a 11.0 weekly interval (198.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 326.0, "avg_administrations": 13}, {"drug": "SECUKINUMAB", "avg_dose_mg": 251.8, "avg_administrations": 26}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £11,613
first_seen: 2021-03-18
last_seen: 2025-10-19
first_seen_parent: 2020-10-13
last_seen_parent: 2025-09-22
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 347.5, "avg_administrations": 26}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7 times with a 5.4 weekly interval (37.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - SECUKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - SECUKINUMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £19,555
first_seen: 2021-07-09
last_seen: 2024-02-17
first_seen_parent: 2021-02-21
last_seen_parent: 2025-01-13
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 5 times with a 11.4 weekly interval (57.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 19 times with a 10.8 weekly interval (205.2 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 338.3, "avg_administrations": 17}, {"drug": "ADALIMUMAB", "avg_dose_mg": 156.3, "avg_administrations": 23}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £19,519
first_seen: 2020-10-25
last_seen: 2025-10-01
first_seen_parent: 2020-08-04
last_seen_parent: 2025-09-19
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 425.2, "avg_administrations": 14}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 7 times with a 4.5 weekly interval (31.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £18,530
first_seen: 2021-09-01
last_seen: 2025-06-13
first_seen_parent: 2017-11-14
last_seen_parent: 2025-12-14
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 62.1, "avg_administrations": 12}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 17 times with a 10.8 weekly interval (183.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £9,266
first_seen: 2019-11-11
last_seen: 2025-08-21
first_seen_parent: 2019-12-17
last_seen_parent: 2025-11-05
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 213.3, "avg_administrations": 23}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 17 times with a 6.2 weekly interval (105.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - ETANERCEPT
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - ETANERCEPT - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £16,715
first_seen: 2021-10-27
last_seen: 2024-12-07
first_seen_parent: 2021-05-15
last_seen_parent: 2024-06-06
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 13 times with a 7.5 weekly interval (97.5 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 17 times with a 10.3 weekly interval (175.1 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 134.4, "avg_administrations": 9}, {"drug": "NATALIZUMAB", "avg_dose_mg": 154.0, "avg_administrations": 18}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £7,570
first_seen: 2021-08-04
last_seen: 2025-04-20
first_seen_parent: 2020-07-31
last_seen_parent: 2025-12-22
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 393.8, "avg_administrations": 30}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 26 times with a 9.5 weekly interval (247.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - USTEKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - USTEKINUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £15,616
first_seen: 2019-01-04
last_seen: 2024-01-27
first_seen_parent: 2020-09-05
last_seen_parent: 2025-03-13
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 14 times with a 5.9 weekly interval (82.6 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 22 times with a 6.0 weekly interval (132.0 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 442.8, "avg_administrations": 23}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 438.0, "avg_administrations": 4}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - USTEKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - USTEKINUMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £4,103
first_seen: 2020-02-17
last_seen: 2025-01-18
first_seen_parent: 2019-01-17
last_seen_parent: 2024-08-14
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 5 times with a 6.3 weekly interval (31.5 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 23 times with a 3.1 weekly interval (71.3 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 378.3, "avg_administrations": 29}, {"drug": "ADALIMUMAB", "avg_dose_mg": 264.8, "avg_administrations": 16}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £5,800
first_seen: 2019-04-22
last_seen: 2024-04-30
first_seen_parent: 2020-08-21
last_seen_parent: 2024-10-03
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 433.5, "avg_administrations": 28}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 18 times with a 7.7 weekly interval (138.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £4,450
first_seen: 2018-04-15
last_seen: 2025-10-04
first_seen_parent: 2019-10-07
last_seen_parent: 2024-11-24
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 435.2, "avg_administrations": 25}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8 times with a 9.3 weekly interval (74.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £18,407
first_seen: 2018-11-18
last_seen: 2025-11-14
first_seen_parent: 2020-08-19
last_seen_parent: 2025-05-23
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 472.8, "avg_administrations": 13}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 28 times with a 3.7 weekly interval (103.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - ETANERCEPT
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - ETANERCEPT - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £17,066
first_seen: 2019-10-07
last_seen: 2024-02-21
first_seen_parent: 2019-06-18
last_seen_parent: 2025-06-16
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ETANERCEPT|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 14 times with a 4.9 weekly interval (68.6 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 29 times with a 10.7 weekly interval (310.3 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 443.2, "avg_administrations": 19}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 452.1, "avg_administrations": 28}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - ETANERCEPT
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - ETANERCEPT - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £18,294
first_seen: 2022-07-29
last_seen: 2024-10-07
first_seen_parent: 2018-09-16
last_seen_parent: 2025-11-18
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ETANERCEPT|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 9 times with a 11.0 weekly interval (99.0 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 5 times with a 3.6 weekly interval (18.0 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 84.9, "avg_administrations": 23}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 57.2, "avg_administrations": 27}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £18,088
first_seen: 2018-10-05
last_seen: 2024-05-25
first_seen_parent: 2017-11-25
last_seen_parent: 2025-03-09
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 355.0, "avg_administrations": 5}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 28 times with a 6.0 weekly interval (168.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - BARICITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - BARICITINIB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £10,325
first_seen: 2021-12-09
last_seen: 2024-10-07
first_seen_parent: 2019-08-08
last_seen_parent: 2024-09-12
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: BARICITINIB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 27 times with a 3.7 weekly interval (99.9 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 4 times with a 10.6 weekly interval (42.4 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 346.7, "avg_administrations": 9}, {"drug": "RITUXIMAB", "avg_dose_mg": 132.3, "avg_administrations": 22}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - BARICITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - BARICITINIB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £16,795
first_seen: 2020-08-13
last_seen: 2025-08-04
first_seen_parent: 2018-07-16
last_seen_parent: 2025-03-09
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: BARICITINIB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 14 times with a 10.7 weekly interval (149.8 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 24 times with a 11.0 weekly interval (264.0 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 224.5, "avg_administrations": 27}, {"drug": "ADALIMUMAB", "avg_dose_mg": 365.3, "avg_administrations": 29}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £22,444
first_seen: 2021-06-26
last_seen: 2024-03-18
first_seen_parent: 2018-05-25
last_seen_parent: 2025-10-10
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 158.0, "avg_administrations": 9}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 5 times with a 2.1 weekly interval (10.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £12,927
first_seen: 2018-08-24
last_seen: 2025-08-25
first_seen_parent: 2018-06-07
last_seen_parent: 2025-09-20
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 318.2, "avg_administrations": 21}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 23 times with a 2.5 weekly interval (57.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - VEDOLIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - VEDOLIZUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £13,609
first_seen: 2020-03-16
last_seen: 2025-06-04
first_seen_parent: 2019-06-07
last_seen_parent: 2025-12-18
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 5 times with a 3.1 weekly interval (15.5 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 11 times with a 6.2 weekly interval (68.2 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 94.1, "avg_administrations": 28}, {"drug": "RITUXIMAB", "avg_dose_mg": 239.4, "avg_administrations": 17}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - VEDOLIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - VEDOLIZUMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £6,724
first_seen: 2019-10-15
last_seen: 2025-04-05
first_seen_parent: 2019-02-25
last_seen_parent: 2025-03-06
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 8 times with a 4.8 weekly interval (38.4 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 22 times with a 3.7 weekly interval (81.4 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 353.7, "avg_administrations": 23}, {"drug": "BARICITINIB", "avg_dose_mg": 189.7, "avg_administrations": 6}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £12,803
first_seen: 2019-11-17
last_seen: 2025-10-30
first_seen_parent: 2019-11-11
last_seen_parent: 2025-07-11
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 130.3, "avg_administrations": 15}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 12 times with a 5.1 weekly interval (61.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £18,015
first_seen: 2019-01-13
last_seen: 2025-03-18
first_seen_parent: 2019-05-26
last_seen_parent: 2025-07-18
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 370.4, "avg_administrations": 20}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 9 times with a 7.1 weekly interval (63.9 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £21,525
first_seen: 2021-11-25
last_seen: 2024-11-18
first_seen_parent: 2019-01-14
last_seen_parent: 2024-09-18
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 227.6, "avg_administrations": 30}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 13 times with a 6.3 weekly interval (81.9 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £13,512
first_seen: 2022-06-19
last_seen: 2024-07-16
first_seen_parent: 2021-08-09
last_seen_parent: 2025-04-17
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 18 times with a 4.8 weekly interval (86.4 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 29 times with a 10.8 weekly interval (313.2 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 297.3, "avg_administrations": 20}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 445.2, "avg_administrations": 28}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £7,344
first_seen: 2019-01-21
last_seen: 2025-03-07
first_seen_parent: 2017-08-19
last_seen_parent: 2024-06-05
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 196.9, "avg_administrations": 12}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 17 times with a 3.8 weekly interval (64.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £9,509
first_seen: 2021-10-31
last_seen: 2024-04-11
first_seen_parent: 2017-03-09
last_seen_parent: 2024-03-08
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 71.9, "avg_administrations": 22}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 6 times with a 3.3 weekly interval (19.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - IBRUTINIB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £4,339
first_seen: 2019-02-03
last_seen: 2024-05-11
first_seen_parent: 2020-08-14
last_seen_parent: 2024-01-07
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 20 times with a 7.9 weekly interval (158.0 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 10 times with a 6.5 weekly interval (65.0 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 360.0, "avg_administrations": 23}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 407.4, "avg_administrations": 4}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £25,600
first_seen: 2019-06-01
last_seen: 2025-10-03
first_seen_parent: 2017-04-09
last_seen_parent: 2024-06-29
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 146.6, "avg_administrations": 5}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 27 times with a 5.4 weekly interval (145.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £24,016
first_seen: 2018-10-18
last_seen: 2024-10-22
first_seen_parent: 2020-09-08
last_seen_parent: 2025-12-01
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 111.3, "avg_administrations": 27}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 23 times with a 7.5 weekly interval (172.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - OCRELIZUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £7,357
first_seen: 2019-12-26
last_seen: 2025-12-28
first_seen_parent: 2019-02-09
last_seen_parent: 2024-05-01
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 12 times with a 7.3 weekly interval (87.6 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 6 times with a 7.2 weekly interval (43.2 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 447.9, "avg_administrations": 17}, {"drug": "USTEKINUMAB", "avg_dose_mg": 225.9, "avg_administrations": 15}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - OCRELIZUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £11,234
first_seen: 2019-01-01
last_seen: 2025-06-26
first_seen_parent: 2021-01-05
last_seen_parent: 2024-07-02
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 9 times with a 11.0 weekly interval (99.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 11 times with a 9.0 weekly interval (99.0 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 271.8, "avg_administrations": 23}, {"drug": "ETANERCEPT", "avg_dose_mg": 173.8, "avg_administrations": 30}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £22,475
first_seen: 2018-07-08
last_seen: 2025-08-18
first_seen_parent: 2018-04-01
last_seen_parent: 2024-09-05
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 272.6, "avg_administrations": 30}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 22 times with a 2.0 weekly interval (44.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £11,254
first_seen: 2018-09-27
last_seen: 2024-02-27
first_seen_parent: 2018-01-08
last_seen_parent: 2025-07-05
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 260.6, "avg_administrations": 9}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 18 times with a 5.4 weekly interval (97.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £18,608
first_seen: 2020-05-27
last_seen: 2024-11-02
first_seen_parent: 2017-03-15
last_seen_parent: 2024-08-03
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 142.5, "avg_administrations": 29}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: ONCOLOGY
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 11 times with a 9.9 weekly interval (108.9 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - TRASTUZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - TRASTUZUMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £17,238
first_seen: 2020-05-24
last_seen: 2025-09-26
first_seen_parent: 2018-10-22
last_seen_parent: 2025-11-01
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 13 times with a 8.2 weekly interval (106.6 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 14 times with a 7.3 weekly interval (102.2 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 379.9, "avg_administrations": 26}, {"drug": "ADALIMUMAB", "avg_dose_mg": 384.2, "avg_administrations": 18}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £9,653
first_seen: 2018-09-26
last_seen: 2025-06-13
first_seen_parent: 2020-03-02
last_seen_parent: 2024-12-04
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 217.3, "avg_administrations": 14}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 10 times with a 8.0 weekly interval (80.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £7,611
first_seen: 2021-06-15
last_seen: 2025-09-02
first_seen_parent: 2018-05-05
last_seen_parent: 2025-06-24
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 242.3, "avg_administrations": 26}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 14 times with a 9.6 weekly interval (134.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £4,670
first_seen: 2021-07-03
last_seen: 2024-11-14
first_seen_parent: 2018-06-04
last_seen_parent: 2024-12-01
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 304.5, "avg_administrations": 4}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10 times with a 10.3 weekly interval (103.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £17,056
first_seen: 2019-04-14
last_seen: 2025-03-21
first_seen_parent: 2019-07-11
last_seen_parent: 2024-09-05
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 26 times with a 8.3 weekly interval (215.8 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 12 times with a 5.6 weekly interval (67.2 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 177.2, "avg_administrations": 11}, {"drug": "INFLIXIMAB", "avg_dose_mg": 275.7, "avg_administrations": 15}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £4,885
first_seen: 2022-01-23
last_seen: 2025-04-26
first_seen_parent: 2018-08-18
last_seen_parent: 2024-11-12
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 11 times with a 9.6 weekly interval (105.6 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 5 times with a 9.3 weekly interval (46.5 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 113.7, "avg_administrations": 23}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 317.8, "avg_administrations": 7}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £12,641
first_seen: 2020-11-07
last_seen: 2025-09-01
first_seen_parent: 2020-04-28
last_seen_parent: 2024-11-06
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 397.3, "avg_administrations": 17}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 28 times with a 4.2 weekly interval (117.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £17,113
first_seen: 2020-05-18
last_seen: 2025-06-21
first_seen_parent: 2019-12-31
last_seen_parent: 2024-06-18
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 28 times with a 10.3 weekly interval (288.4 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 9 times with a 10.4 weekly interval (93.6 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 401.7, "avg_administrations": 8}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 481.0, "avg_administrations": 27}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £18,154
first_seen: 2021-06-29
last_seen: 2025-04-29
first_seen_parent: 2018-11-03
last_seen_parent: 2024-12-14
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 324.9, "avg_administrations": 28}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 20 times with a 6.9 weekly interval (138.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £8,524
first_seen: 2020-12-27
last_seen: 2025-04-14
first_seen_parent: 2020-07-26
last_seen_parent: 2024-11-19
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 416.6, "avg_administrations": 27}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 28 times with a 7.8 weekly interval (218.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - SECUKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - SECUKINUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £6,530
first_seen: 2021-05-30
last_seen: 2024-12-13
first_seen_parent: 2021-08-31
last_seen_parent: 2025-05-31
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 27 times with a 3.4 weekly interval (91.8 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 13 times with a 5.5 weekly interval (71.5 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 161.1, "avg_administrations": 22}, {"drug": "NIVOLUMAB", "avg_dose_mg": 154.5, "avg_administrations": 6}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £10,630
first_seen: 2020-11-16
last_seen: 2025-04-27
first_seen_parent: 2020-05-22
last_seen_parent: 2025-08-01
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 176.8, "avg_administrations": 16}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 25 times with a 9.1 weekly interval (227.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - ADALIMUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - ADALIMUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £7,275
first_seen: 2022-05-07
last_seen: 2025-10-07
first_seen_parent: 2020-10-25
last_seen_parent: 2025-09-20
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 19 times with a 6.1 weekly interval (115.9 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 28 times with a 8.5 weekly interval (238.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 411.7, "avg_administrations": 7}, {"drug": "SECUKINUMAB", "avg_dose_mg": 282.9, "avg_administrations": 11}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - ADALIMUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - ADALIMUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £5,959
first_seen: 2021-09-30
last_seen: 2025-01-02
first_seen_parent: 2018-05-18
last_seen_parent: 2024-09-19
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9 times with a 8.5 weekly interval (76.5 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 23 times with a 7.1 weekly interval (163.3 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 180.1, "avg_administrations": 5}, {"drug": "RITUXIMAB", "avg_dose_mg": 441.8, "avg_administrations": 13}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £7,143
first_seen: 2019-08-03
last_seen: 2024-01-01
first_seen_parent: 2017-07-24
last_seen_parent: 2024-03-02
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 419.9, "avg_administrations": 7}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 21 times with a 4.6 weekly interval (96.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - ETANERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - ETANERCEPT - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £3,626
first_seen: 2019-05-01
last_seen: 2024-04-10
first_seen_parent: 2020-01-16
last_seen_parent: 2024-04-20
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: ETANERCEPT|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 9 times with a 10.1 weekly interval (90.9 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 16 times with a 4.0 weekly interval (64.0 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 438.8, "avg_administrations": 19}, {"drug": "ADALIMUMAB", "avg_dose_mg": 119.1, "avg_administrations": 26}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £19,854
first_seen: 2018-03-17
last_seen: 2025-11-15
first_seen_parent: 2019-01-01
last_seen_parent: 2024-05-26
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 283.1, "avg_administrations": 6}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 12 times with a 5.4 weekly interval (64.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £8,598
first_seen: 2018-02-07
last_seen: 2024-04-28
first_seen_parent: 2020-07-20
last_seen_parent: 2024-04-06
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 491.4, "avg_administrations": 17}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 23 times with a 4.6 weekly interval (105.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £5,056
first_seen: 2021-12-16
last_seen: 2024-07-30
first_seen_parent: 2020-03-08
last_seen_parent: 2024-07-24
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 200.6, "avg_administrations": 22}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 25 times with a 2.6 weekly interval (65.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £7,613
first_seen: 2018-06-22
last_seen: 2024-04-10
first_seen_parent: 2019-03-13
last_seen_parent: 2025-06-07
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 426.9, "avg_administrations": 14}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 29 times with a 11.4 weekly interval (330.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - INFLIXIMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - INFLIXIMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £8,165
first_seen: 2020-10-16
last_seen: 2025-04-05
first_seen_parent: 2018-11-29
last_seen_parent: 2025-02-18
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 24 times with a 9.1 weekly interval (218.4 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 10 times with a 8.8 weekly interval (88.0 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 406.2, "avg_administrations": 27}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 127.1, "avg_administrations": 9}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - INFLIXIMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - INFLIXIMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £10,897
first_seen: 2019-11-02
last_seen: 2024-03-07
first_seen_parent: 2021-08-07
last_seen_parent: 2025-06-21
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 13 times with a 10.2 weekly interval (132.6 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 6 times with a 3.8 weekly interval (22.8 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 350.1, "avg_administrations": 26}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 278.9, "avg_administrations": 8}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £20,395
first_seen: 2019-10-24
last_seen: 2024-06-08
first_seen_parent: 2018-12-08
last_seen_parent: 2024-01-05
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 153.8, "avg_administrations": 28}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 4 times with a 9.6 weekly interval (38.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - TOFACITINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - TOFACITINIB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £7,280
first_seen: 2019-02-21
last_seen: 2025-11-15
first_seen_parent: 2018-05-04
last_seen_parent: 2025-08-01
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 13 times with a 11.3 weekly interval (146.9 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 26 times with a 11.8 weekly interval (306.8 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 439.2, "avg_administrations": 27}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 150.5, "avg_administrations": 7}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - TOFACITINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - TOFACITINIB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £9,303
first_seen: 2022-03-13
last_seen: 2025-11-16
first_seen_parent: 2018-05-19
last_seen_parent: 2025-05-21
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 27 times with a 8.2 weekly interval (221.4 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 17 times with a 8.7 weekly interval (147.9 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 128.0, "avg_administrations": 10}, {"drug": "SECUKINUMAB", "avg_dose_mg": 178.7, "avg_administrations": 6}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £13,689
first_seen: 2018-08-27
last_seen: 2025-01-18
first_seen_parent: 2018-10-01
last_seen_parent: 2025-07-28
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 447.4, "avg_administrations": 20}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 23 times with a 5.5 weekly interval (126.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £20,471
first_seen: 2021-06-26
last_seen: 2025-08-28
first_seen_parent: 2020-12-18
last_seen_parent: 2024-03-10
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 465.6, "avg_administrations": 26}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 6 times with a 7.1 weekly interval (42.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - RITUXIMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £8,300
first_seen: 2020-09-04
last_seen: 2024-02-28
first_seen_parent: 2021-05-05
last_seen_parent: 2025-10-25
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 22 times with a 2.1 weekly interval (46.2 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 28 times with a 3.7 weekly interval (103.6 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 377.4, "avg_administrations": 23}, {"drug": "TOFACITINIB", "avg_dose_mg": 366.0, "avg_administrations": 20}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - RITUXIMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £5,586
first_seen: 2019-03-25
last_seen: 2025-11-19
first_seen_parent: 2020-07-03
last_seen_parent: 2024-05-14
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 12 times with a 6.4 weekly interval (76.8 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 4 times with a 6.3 weekly interval (25.2 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 56.4, "avg_administrations": 8}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 490.6, "avg_administrations": 15}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £9,285
first_seen: 2019-04-01
last_seen: 2024-06-25
first_seen_parent: 2017-12-15
last_seen_parent: 2024-02-11
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 247.3, "avg_administrations": 5}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 4 times with a 6.6 weekly interval (26.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £10,340
first_seen: 2020-09-05
last_seen: 2024-01-04
first_seen_parent: 2017-08-18
last_seen_parent: 2025-09-04
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 258.3, "avg_administrations": 26}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 11 times with a 2.6 weekly interval (28.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £9,664
first_seen: 2019-07-06
last_seen: 2024-11-09
first_seen_parent: 2020-11-28
last_seen_parent: 2024-06-05
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 420.8, "avg_administrations": 21}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 6 times with a 4.7 weekly interval (28.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £27,113
first_seen: 2021-09-24
last_seen: 2025-10-23
first_seen_parent: 2020-08-11
last_seen_parent: 2025-09-21
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 147.3, "avg_administrations": 16}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 27 times with a 9.6 weekly interval (259.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - BEVACIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - BEVACIZUMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £9,735
first_seen: 2022-06-15
last_seen: 2024-04-18
first_seen_parent: 2020-09-30
last_seen_parent: 2024-04-22
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 9 times with a 10.2 weekly interval (91.8 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 18 times with a 6.0 weekly interval (108.0 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 199.0, "avg_administrations": 13}, {"drug": "BARICITINIB", "avg_dose_mg": 148.4, "avg_administrations": 22}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - BEVACIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - BEVACIZUMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £4,654
first_seen: 2021-01-19
last_seen: 2024-03-30
first_seen_parent: 2018-08-26
last_seen_parent: 2024-07-02
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 14 times with a 10.0 weekly interval (140.0 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 7 times with a 5.8 weekly interval (40.6 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 77.5, "avg_administrations": 29}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 188.1, "avg_administrations": 13}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £22,051
first_seen: 2021-02-25
last_seen: 2024-02-03
first_seen_parent: 2020-05-28
last_seen_parent: 2024-01-07
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 279.0, "avg_administrations": 19}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 29 times with a 3.6 weekly interval (104.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - ADALIMUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - ADALIMUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £7,687
first_seen: 2021-11-13
last_seen: 2025-09-01
first_seen_parent: 2018-04-18
last_seen_parent: 2024-10-21
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7 times with a 4.3 weekly interval (30.1 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 30 times with a 6.3 weekly interval (189.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 298.6, "avg_administrations": 7}, {"drug": "TOFACITINIB", "avg_dose_mg": 241.2, "avg_administrations": 20}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £11,924
first_seen: 2021-01-02
last_seen: 2024-10-03
first_seen_parent: 2018-10-22
last_seen_parent: 2024-08-12
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 130.1, "avg_administrations": 13}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6 times with a 2.5 weekly interval (15.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £17,409
first_seen: 2018-10-23
last_seen: 2024-03-30
first_seen_parent: 2017-12-21
last_seen_parent: 2024-05-13
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 342.8, "avg_administrations": 10}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 22 times with a 6.9 weekly interval (151.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - RANIBIZUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £16,066
first_seen: 2021-05-27
last_seen: 2024-10-19
first_seen_parent: 2021-11-24
last_seen_parent: 2024-01-15
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4 times with a 7.7 weekly interval (30.8 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 18 times with a 10.9 weekly interval (196.2 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 387.0, "avg_administrations": 26}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 380.4, "avg_administrations": 21}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £16,599
first_seen: 2019-02-02
last_seen: 2025-08-23
first_seen_parent: 2019-05-13
last_seen_parent: 2025-05-29
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 360.5, "avg_administrations": 10}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 30 times with a 5.7 weekly interval (171.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £5,029
first_seen: 2018-12-06
last_seen: 2025-04-22
first_seen_parent: 2018-11-27
last_seen_parent: 2024-12-05
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 282.0, "avg_administrations": 16}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 22 times with a 6.7 weekly interval (147.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - ETANERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - ETANERCEPT - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £13,832
first_seen: 2021-09-14
last_seen: 2025-06-11
first_seen_parent: 2021-01-04
last_seen_parent: 2025-04-04
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 28 times with a 7.5 weekly interval (210.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 11 times with a 7.1 weekly interval (78.1 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 297.8, "avg_administrations": 15}, {"drug": "USTEKINUMAB", "avg_dose_mg": 336.8, "avg_administrations": 15}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - ETANERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - ETANERCEPT - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £7,898
first_seen: 2020-09-21
last_seen: 2024-03-18
first_seen_parent: 2020-01-30
last_seen_parent: 2025-09-22
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 25 times with a 3.1 weekly interval (77.5 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 4 times with a 4.1 weekly interval (16.4 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 294.0, "avg_administrations": 11}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 148.2, "avg_administrations": 29}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £7,395
first_seen: 2021-12-10
last_seen: 2024-11-18
first_seen_parent: 2019-03-16
last_seen_parent: 2025-06-19
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 251.9, "avg_administrations": 5}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 16 times with a 8.7 weekly interval (139.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £6,000
first_seen: 2020-12-26
last_seen: 2024-08-11
first_seen_parent: 2020-03-23
last_seen_parent: 2024-01-16
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 294.6, "avg_administrations": 19}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 25 times with a 3.7 weekly interval (92.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - BARICITINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - BARICITINIB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £7,197
first_seen: 2020-10-04
last_seen: 2025-07-01
first_seen_parent: 2021-06-24
last_seen_parent: 2025-06-11
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: BARICITINIB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 10 times with a 3.4 weekly interval (34.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 18 times with a 3.9 weekly interval (70.2 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 443.5, "avg_administrations": 5}, {"drug": "SECUKINUMAB", "avg_dose_mg": 145.7, "avg_administrations": 17}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - BARICITINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - BARICITINIB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £16,356
first_seen: 2020-11-30
last_seen: 2024-03-17
first_seen_parent: 2019-11-17
last_seen_parent: 2025-03-24
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: BARICITINIB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 19 times with a 7.0 weekly interval (133.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 11 times with a 4.8 weekly interval (52.8 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 103.6, "avg_administrations": 9}, {"drug": "USTEKINUMAB", "avg_dose_mg": 482.4, "avg_administrations": 14}]


date_filter_id: 1yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £14,489
first_seen: 2021-07-04
last_seen: 2025-10-16
first_seen_parent: 2017-01-09
last_seen_parent: 2024-04-18
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 341.6, "avg_administrations": 24}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 23 times with a 4.0 weekly interval (92.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £3,969
first_seen: 2020-11-21
last_seen: 2024-04-09
first_seen_parent: 2018-01-31
last_seen_parent: 2025-12-19
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 312.2, "avg_administrations": 21}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 26 times with a 4.0 weekly interval (104.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - SECUKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - SECUKINUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £15,757
first_seen: 2020-01-24
last_seen: 2024-06-23
first_seen_parent: 2019-11-28
last_seen_parent: 2025-02-14
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 6 times with a 10.2 weekly interval (61.2 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 26 times with a 2.3 weekly interval (59.8 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 403.7, "avg_administrations": 22}, {"drug": "NIVOLUMAB", "avg_dose_mg": 489.7, "avg_administrations": 8}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - SECUKINUMAB
labels: TOFACITINIB
cost_pp_pa: £6,746
first_seen: 2019-10-10
last_seen: 2024-01-18
first_seen_parent: 2019-08-17
last_seen_parent: 2024-04-30
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - SECUKINUMAB - TOFACITINIB

average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 9 times with a 3.2 weekly interval (28.8 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 18 times with a 8.2 weekly interval (147.6 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 99.3, "avg_administrations": 28}, {"drug": "TOFACITINIB", "avg_dose_mg": 494.4, "avg_administrations": 7}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £10,453
first_seen: 2020-12-05
last_seen: 2024-10-04
first_seen_parent: 2018-07-06
last_seen_parent: 2025-12-18
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 230.0, "avg_administrations": 29}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 20 times with a 9.3 weekly interval (186.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Atopic dermatitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £23,833
first_seen: 2021-07-23
last_seen: 2025-11-07
first_seen_parent: 2017-02-07
last_seen_parent: 2024-01-27
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 94.9, "avg_administrations": 10}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 16 times with a 6.4 weekly interval (102.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £8,815
first_seen: 2020-03-09
last_seen: 2025-07-07
first_seen_parent: 2017-01-03
last_seen_parent: 2024-02-21
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 329.6, "avg_administrations": 11}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 30 times with a 9.3 weekly interval (279.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Colorectal cancer - BEVACIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Colorectal cancer - BEVACIZUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £9,875
first_seen: 2021-08-17
last_seen: 2024-01-08
first_seen_parent: 2019-05-31
last_seen_parent: 2025-11-17
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BEVACIZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 5 times with a 9.0 weekly interval (45.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 29 times with a 4.7 weekly interval (136.3 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 98.6, "avg_administrations": 27}, {"drug": "TOFACITINIB", "avg_dose_mg": 180.8, "avg_administrations": 26}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Colorectal cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £23,871
first_seen: 2019-05-13
last_seen: 2025-07-19
first_seen_parent: 2019-08-30
last_seen_parent: 2024-07-27
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 160.9, "avg_administrations": 18}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 20 times with a 3.3 weekly interval (66.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £9,212
first_seen: 2019-05-03
last_seen: 2024-04-26
first_seen_parent: 2019-09-08
last_seen_parent: 2024-12-17
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 179.2, "avg_administrations": 10}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 28 times with a 5.8 weekly interval (162.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - VEDOLIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - VEDOLIZUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £10,412
first_seen: 2020-11-27
last_seen: 2024-05-21
first_seen_parent: 2021-05-06
last_seen_parent: 2024-11-07
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: VEDOLIZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 29 times with a 3.0 weekly interval (87.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 21 times with a 3.9 weekly interval (81.9 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 293.9, "avg_administrations": 19}, {"drug": "TOFACITINIB", "avg_dose_mg": 129.1, "avg_administrations": 18}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - VEDOLIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - VEDOLIZUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £4,616
first_seen: 2022-04-18
last_seen: 2024-01-29
first_seen_parent: 2021-03-19
last_seen_parent: 2024-06-06
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: VEDOLIZUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 6 times with a 7.0 weekly interval (42.0 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 7 times with a 10.7 weekly interval (74.9 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 190.5, "avg_administrations": 6}, {"drug": "NIVOLUMAB", "avg_dose_mg": 454.6, "avg_administrations": 21}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £10,072
first_seen: 2019-09-25
last_seen: 2025-05-28
first_seen_parent: 2018-03-25
last_seen_parent: 2024-12-04
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 159.8, "avg_administrations": 14}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 6 times with a 11.5 weekly interval (69.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £14,001
first_seen: 2019-02-16
last_seen: 2024-08-04
first_seen_parent: 2018-10-07
last_seen_parent: 2024-01-20
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 110.6, "avg_administrations": 6}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 28 times with a 11.9 weekly interval (333.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Diabetic macular oedema
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £14,541
first_seen: 2018-10-09
last_seen: 2024-10-16
first_seen_parent: 2018-01-17
last_seen_parent: 2025-04-21
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 141.9, "avg_administrations": 25}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 12 times with a 10.5 weekly interval (126.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Giant cell arteritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £17,565
first_seen: 2021-07-15
last_seen: 2025-07-24
first_seen_parent: 2019-05-20
last_seen_parent: 2025-01-19
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 94.5, "avg_administrations": 27}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 30 times with a 7.9 weekly interval (237.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HER2+ breast cancer - TRASTUZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HER2+ breast cancer - TRASTUZUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £9,749
first_seen: 2020-10-22
last_seen: 2025-05-16
first_seen_parent: 2021-08-27
last_seen_parent: 2025-08-03
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TRASTUZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 22 times with a 10.0 weekly interval (220.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 27 times with a 8.5 weekly interval (229.5 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 235.8, "avg_administrations": 5}, {"drug": "INFLIXIMAB", "avg_dose_mg": 222.4, "avg_administrations": 9}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HER2+ breast cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £17,192
first_seen: 2020-12-05
last_seen: 2024-08-20
first_seen_parent: 2019-09-11
last_seen_parent: 2024-08-03
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 178.9, "avg_administrations": 10}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 14 times with a 2.7 weekly interval (37.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Mantle cell lymphoma - IBRUTINIB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Mantle cell lymphoma - IBRUTINIB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £11,513
first_seen: 2020-01-19
last_seen: 2024-12-11
first_seen_parent: 2019-11-16
last_seen_parent: 2024-09-04
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: IBRUTINIB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 22 times with a 9.6 weekly interval (211.2 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 18 times with a 10.4 weekly interval (187.2 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 160.4, "avg_administrations": 16}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 261.3, "avg_administrations": 7}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Mantle cell lymphoma - IBRUTINIB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Mantle cell lymphoma - IBRUTINIB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £5,536
first_seen: 2022-10-26
last_seen: 2024-01-11
first_seen_parent: 2019-03-02
last_seen_parent: 2025-11-09
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: IBRUTINIB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 5 times with a 8.0 weekly interval (40.0 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 18 times with a 5.5 weekly interval (99.0 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 150.4, "avg_administrations": 29}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 79.4, "avg_administrations": 26}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Mantle cell lymphoma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £8,862
first_seen: 2018-05-31
last_seen: 2025-09-08
first_seen_parent: 2018-03-02
last_seen_parent: 2024-01-26
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 390.9, "avg_administrations": 9}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 19 times with a 11.4 weekly interval (216.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Melanoma - PEMBROLIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Melanoma - PEMBROLIZUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £7,822
first_seen: 2021-11-26
last_seen: 2024-06-13
first_seen_parent: 2021-02-13
last_seen_parent: 2025-06-26
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 11 times with a 11.4 weekly interval (125.4 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 29 times with a 11.2 weekly interval (324.8 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 70.3, "avg_administrations": 13}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 390.8, "avg_administrations": 16}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Melanoma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £11,832
first_seen: 2019-03-25
last_seen: 2024-04-12
first_seen_parent: 2017-04-27
last_seen_parent: 2025-07-13
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 218.9, "avg_administrations": 15}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 8 times with a 7.5 weekly interval (60.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple myeloma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £5,338
first_seen: 2018-10-11
last_seen: 2024-02-03
first_seen_parent: 2018-12-13
last_seen_parent: 2025-08-19
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 185.6, "avg_administrations": 24}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 16 times with a 6.0 weekly interval (96.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis - OCRELIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis - OCRELIZUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £7,122
first_seen: 2019-06-03
last_seen: 2025-12-05
first_seen_parent: 2018-02-28
last_seen_parent: 2024-04-19
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: OCRELIZUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 4 times with a 8.2 weekly interval (32.8 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 21 times with a 7.8 weekly interval (163.8 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 251.4, "avg_administrations": 12}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 192.1, "avg_administrations": 6}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis - OCRELIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis - OCRELIZUMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £4,539
first_seen: 2020-10-30
last_seen: 2025-05-06
first_seen_parent: 2020-12-13
last_seen_parent: 2024-10-12
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: OCRELIZUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 25 times with a 10.1 weekly interval (252.5 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 25 times with a 9.3 weekly interval (232.5 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 223.9, "avg_administrations": 19}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 494.7, "avg_administrations": 11}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £5,193
first_seen: 2019-02-20
last_seen: 2024-09-02
first_seen_parent: 2020-02-07
last_seen_parent: 2024-09-06
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 395.7, "avg_administrations": 23}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 25 times with a 7.8 weekly interval (195.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £4,161
first_seen: 2021-06-15
last_seen: 2024-06-15
first_seen_parent: 2020-05-12
last_seen_parent: 2024-12-02
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 287.1, "avg_administrations": 23}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 8 times with a 8.5 weekly interval (68.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-Hodgkin lymphoma - RITUXIMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £17,634
first_seen: 2020-04-21
last_seen: 2024-04-04
first_seen_parent: 2018-06-17
last_seen_parent: 2025-05-21
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 12 times with a 9.9 weekly interval (118.8 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 18 times with a 10.7 weekly interval (192.6 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 124.8, "avg_administrations": 19}, {"drug": "ETANERCEPT", "avg_dose_mg": 473.3, "avg_administrations": 13}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-Hodgkin lymphoma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £4,771
first_seen: 2020-12-25
last_seen: 2025-12-15
first_seen_parent: 2019-11-20
last_seen_parent: 2024-01-03
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 102.8, "avg_administrations": 30}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 8 times with a 2.9 weekly interval (23.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: TOFACITINIB
cost_pp_pa: £10,217
first_seen: 2019-02-21
last_seen: 2025-11-19
first_seen_parent: 2019-10-04
last_seen_parent: 2024-11-05
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB - TOFACITINIB

average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 29 times with a 5.3 weekly interval (153.7 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 11 times with a 10.5 weekly interval (115.5 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 299.7, "avg_administrations": 14}, {"drug": "TOFACITINIB", "avg_dose_mg": 309.9, "avg_administrations": 17}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £14,774
first_seen: 2021-03-15
last_seen: 2024-09-17
first_seen_parent: 2020-07-01
last_seen_parent: 2025-07-06
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 358.3, "avg_administrations": 15}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 25 times with a 4.8 weekly interval (120.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £26,386
first_seen: 2018-10-04
last_seen: 2025-03-28
first_seen_parent: 2020-09-06
last_seen_parent: 2025-02-12
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 429.5, "avg_administrations": 7}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 23 times with a 9.2 weekly interval (211.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £11,709
first_seen: 2019-01-24
last_seen: 2025-04-28
first_seen_parent: 2020-09-30
last_seen_parent: 2025-05-26
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 112.0, "avg_administrations": 24}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 21 times with a 6.0 weekly interval (126.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - ADALIMUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - ADALIMUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £8,595
first_seen: 2020-02-14
last_seen: 2025-05-05
first_seen_parent: 2019-07-30
last_seen_parent: 2025-07-04
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9 times with a 10.6 weekly interval (95.4 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 10 times with a 8.9 weekly interval (89.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 240.4, "avg_administrations": 11}, {"drug": "INFLIXIMAB", "avg_dose_mg": 84.6, "avg_administrations": 26}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £24,980
first_seen: 2019-10-15
last_seen: 2024-05-20
first_seen_parent: 2020-10-25
last_seen_parent: 2025-07-16
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 277.7, "avg_administrations": 12}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 26 times with a 8.3 weekly interval (215.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £17,169
first_seen: 2019-04-01
last_seen: 2025-06-06
first_seen_parent: 2019-07-10
last_seen_parent: 2025-01-16
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 287.2, "avg_administrations": 28}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 30 times with a 6.5 weekly interval (195.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £26,849
first_seen: 2018-08-04
last_seen: 2024-03-07
first_seen_parent: 2017-07-13
last_seen_parent: 2025-05-29
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 311.3, "avg_administrations": 5}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 5 times with a 6.7 weekly interval (33.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £21,958
first_seen: 2019-02-20
last_seen: 2024-09-18
first_seen_parent: 2018-09-07
last_seen_parent: 2025-03-15
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 340.1, "avg_administrations": 27}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 26 times with a 11.9 weekly interval (309.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - SECUKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - SECUKINUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £4,296
first_seen: 2020-05-10
last_seen: 2024-07-16
first_seen_parent: 2020-08-03
last_seen_parent: 2025-10-28
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 20 times with a 5.9 weekly interval (118.0 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 14 times with a 10.5 weekly interval (147.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 369.2, "avg_administrations": 15}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 163.4, "avg_administrations": 27}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - SECUKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - SECUKINUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £18,758
first_seen: 2020-01-12
last_seen: 2024-02-08
first_seen_parent: 2019-07-29
last_seen_parent: 2024-04-14
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 22 times with a 7.2 weekly interval (158.4 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 10 times with a 3.5 weekly interval (35.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 321.0, "avg_administrations": 16}, {"drug": "NATALIZUMAB", "avg_dose_mg": 356.7, "avg_administrations": 17}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £17,243
first_seen: 2019-11-25
last_seen: 2024-04-24
first_seen_parent: 2019-11-21
last_seen_parent: 2025-10-24
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 146.3, "avg_administrations": 21}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 21 times with a 9.0 weekly interval (189.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Renal cell carcinoma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £22,004
first_seen: 2019-10-02
last_seen: 2025-12-08
first_seen_parent: 2017-10-30
last_seen_parent: 2024-05-26
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 401.5, "avg_administrations": 15}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 21 times with a 2.8 weekly interval (58.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £7,328
first_seen: 2018-02-10
last_seen: 2025-09-23
first_seen_parent: 2019-08-23
last_seen_parent: 2025-05-14
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 104.1, "avg_administrations": 14}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 12 times with a 9.2 weekly interval (110.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £9,453
first_seen: 2021-05-06
last_seen: 2024-10-04
first_seen_parent: 2020-05-12
last_seen_parent: 2025-06-27
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 76.5, "avg_administrations": 29}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 21 times with a 9.9 weekly interval (207.9 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £6,110
first_seen: 2018-03-20
last_seen: 2024-02-23
first_seen_parent: 2018-08-15
last_seen_parent: 2024-03-11
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 159.5, "avg_administrations": 15}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 4 times with a 8.3 weekly interval (33.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £10,413
first_seen: 2020-05-10
last_seen: 2024-03-14
first_seen_parent: 2017-01-13
last_seen_parent: 2024-02-20
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 274.8, "avg_administrations": 8}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 15 times with a 7.3 weekly interval (109.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £18,837
first_seen: 2021-04-09
last_seen: 2024-02-18
first_seen_parent: 2019-10-11
last_seen_parent: 2025-10-04
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 233.4, "avg_administrations": 12}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 28 times with a 6.5 weekly interval (182.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £19,448
first_seen: 2019-04-02
last_seen: 2025-10-27
first_seen_parent: 2019-01-13
last_seen_parent: 2025-07-03
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 365.0, "avg_administrations": 17}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 10 times with a 8.6 weekly interval (86.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £3,906
first_seen: 2019-08-31
last_seen: 2025-03-17
first_seen_parent: 2020-11-29
last_seen_parent: 2025-02-15
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 478.7, "avg_administrations": 26}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 28 times with a 4.0 weekly interval (112.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - TOFACITINIB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - TOFACITINIB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £14,308
first_seen: 2021-11-11
last_seen: 2025-06-10
first_seen_parent: 2020-08-19
last_seen_parent: 2024-01-24
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOFACITINIB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 4 times with a 4.0 weekly interval (16.0 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 29 times with a 11.6 weekly interval (336.4 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 271.9, "avg_administrations": 12}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 63.9, "avg_administrations": 14}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - TOFACITINIB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - TOFACITINIB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £15,557
first_seen: 2020-12-27
last_seen: 2024-01-02
first_seen_parent: 2018-09-01
last_seen_parent: 2025-12-27
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOFACITINIB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 19 times with a 5.4 weekly interval (102.6 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 21 times with a 11.2 weekly interval (235.2 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 368.6, "avg_administrations": 24}, {"drug": "INFLIXIMAB", "avg_dose_mg": 153.6, "avg_administrations": 21}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £12,790
first_seen: 2020-08-08
last_seen: 2024-07-16
first_seen_parent: 2017-07-22
last_seen_parent: 2024-06-30
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 62.4, "avg_administrations": 27}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 20 times with a 3.4 weekly interval (68.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Uveitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £18,320
first_seen: 2018-05-07
last_seen: 2024-11-11
first_seen_parent: 2019-07-19
last_seen_parent: 2025-02-28
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 177.2, "avg_administrations": 6}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 29 times with a 10.8 weekly interval (313.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - AFLIBERCEPT
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - AFLIBERCEPT - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £21,524
first_seen: 2021-09-02
last_seen: 2024-04-24
first_seen_parent: 2021-04-24
last_seen_parent: 2025-03-05
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: AFLIBERCEPT|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 9 times with a 7.5 weekly interval (67.5 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 8 times with a 4.8 weekly interval (38.4 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 422.3, "avg_administrations": 8}, {"drug": "IBRUTINIB", "avg_dose_mg": 485.1, "avg_administrations": 30}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £9,391
first_seen: 2019-12-17
last_seen: 2025-10-13
first_seen_parent: 2019-06-05
last_seen_parent: 2025-05-16
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 455.5, "avg_administrations": 29}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 5 times with a 7.2 weekly interval (36.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - RANIBIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - RANIBIZUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £18,114
first_seen: 2019-01-28
last_seen: 2024-04-16
first_seen_parent: 2020-07-29
last_seen_parent: 2025-09-03
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RANIBIZUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 18 times with a 3.6 weekly interval (64.8 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 27 times with a 7.4 weekly interval (199.8 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 463.5, "avg_administrations": 19}, {"drug": "RITUXIMAB", "avg_dose_mg": 187.1, "avg_administrations": 22}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £20,288
first_seen: 2020-03-04
last_seen: 2024-07-23
first_seen_parent: 2019-09-02
last_seen_parent: 2025-08-21
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 286.9, "avg_administrations": 29}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 21 times with a 7.3 weekly interval (153.3 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - ETANERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - ETANERCEPT - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £5,633
first_seen: 2021-09-29
last_seen: 2024-05-09
first_seen_parent: 2019-12-19
last_seen_parent: 2024-07-19
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 17 times with a 5.4 weekly interval (91.8 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 9 times with a 10.0 weekly interval (90.0 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 117.9, "avg_administrations": 10}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 164.6, "avg_administrations": 27}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £18,286
first_seen: 2019-01-25
last_seen: 2025-07-12
first_seen_parent: 2019-10-30
last_seen_parent: 2024-03-15
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 366.6, "avg_administrations": 23}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 25 times with a 3.0 weekly interval (75.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £9,056
first_seen: 2021-10-31
last_seen: 2024-10-17
first_seen_parent: 2020-08-16
last_seen_parent: 2025-05-29
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 120.3, "avg_administrations": 13}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 5 times with a 3.3 weekly interval (16.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Atopic dermatitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £23,328
first_seen: 2019-12-27
last_seen: 2025-04-21
first_seen_parent: 2018-03-16
last_seen_parent: 2024-08-03
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 396.4, "avg_administrations": 20}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 28 times with a 9.0 weekly interval (252.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - RITUXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - RITUXIMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £21,944
first_seen: 2022-02-21
last_seen: 2025-12-07
first_seen_parent: 2021-03-30
last_seen_parent: 2025-11-18
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 18 times with a 6.8 weekly interval (122.4 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 30 times with a 10.4 weekly interval (312.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 246.8, "avg_administrations": 21}, {"drug": "BARICITINIB", "avg_dose_mg": 382.0, "avg_administrations": 9}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - RITUXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - RITUXIMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £11,509
first_seen: 2022-10-23
last_seen: 2024-06-21
first_seen_parent: 2018-05-28
last_seen_parent: 2024-02-11
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 15 times with a 6.0 weekly interval (90.0 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 10 times with a 6.2 weekly interval (62.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 98.6, "avg_administrations": 6}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 356.5, "avg_administrations": 24}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £11,723
first_seen: 2020-07-24
last_seen: 2024-08-03
first_seen_parent: 2017-09-30
last_seen_parent: 2024-04-04
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 305.4, "avg_administrations": 29}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 13 times with a 11.2 weekly interval (145.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £19,343
first_seen: 2018-01-02
last_seen: 2024-12-29
first_seen_parent: 2020-07-15
last_seen_parent: 2025-11-21
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 429.9, "avg_administrations": 6}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 26 times with a 10.0 weekly interval (260.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Colorectal cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £18,040
first_seen: 2019-12-30
last_seen: 2025-11-07
first_seen_parent: 2020-05-13
last_seen_parent: 2025-05-17
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 417.6, "avg_administrations": 11}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 19 times with a 4.4 weekly interval (83.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - USTEKINUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - USTEKINUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £10,562
first_seen: 2019-11-29
last_seen: 2025-06-20
first_seen_parent: 2020-04-06
last_seen_parent: 2024-10-02
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: USTEKINUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 6 times with a 5.6 weekly interval (33.6 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 4 times with a 7.4 weekly interval (29.6 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 397.2, "avg_administrations": 5}, {"drug": "IBRUTINIB", "avg_dose_mg": 300.3, "avg_administrations": 20}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £22,770
first_seen: 2021-08-06
last_seen: 2024-03-09
first_seen_parent: 2017-09-01
last_seen_parent: 2025-08-09
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 139.9, "avg_administrations": 21}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 24 times with a 10.2 weekly interval (244.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £5,063
first_seen: 2019-02-26
last_seen: 2024-01-14
first_seen_parent: 2020-04-22
last_seen_parent: 2025-08-27
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 353.8, "avg_administrations": 10}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4 times with a 2.8 weekly interval (11.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Diabetic macular oedema
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £14,547
first_seen: 2019-06-13
last_seen: 2024-12-05
first_seen_parent: 2020-05-19
last_seen_parent: 2024-12-29
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 240.5, "avg_administrations": 20}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 8 times with a 10.3 weekly interval (82.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £17,528
first_seen: 2022-11-30
last_seen: 2025-09-15
first_seen_parent: 2018-09-05
last_seen_parent: 2024-08-25
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOCILIZUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 9 times with a 9.3 weekly interval (83.7 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 6 times with a 4.7 weekly interval (28.2 weeks total treatment length)

average_administered:
[{"drug": "TOCILIZUMAB", "avg_dose_mg": 373.3, "avg_administrations": 25}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 218.8, "avg_administrations": 11}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £5,600
first_seen: 2022-12-08
last_seen: 2024-11-24
first_seen_parent: 2021-08-05
last_seen_parent: 2025-12-26
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOCILIZUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 13 times with a 3.3 weekly interval (42.9 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 15 times with a 10.6 weekly interval (159.0 weeks total treatment length)

average_administered:
[{"drug": "TOCILIZUMAB", "avg_dose_mg": 295.4, "avg_administrations": 12}, {"drug": "IBRUTINIB", "avg_dose_mg": 446.1, "avg_administrations": 29}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Giant cell arteritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £15,587
first_seen: 2019-12-07
last_seen: 2025-06-14
first_seen_parent: 2020-01-29
last_seen_parent: 2024-11-02
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 78.7, "avg_administrations": 8}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 11 times with a 6.3 weekly interval (69.3 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £12,830
first_seen: 2019-10-09
last_seen: 2025-04-05
first_seen_parent: 2018-04-08
last_seen_parent: 2025-01-08
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TRASTUZUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 6 times with a 10.8 weekly interval (64.8 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 17 times with a 8.7 weekly interval (147.9 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 173.1, "avg_administrations": 20}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 208.4, "avg_administrations": 15}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Mantle cell lymphoma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £10,752
first_seen: 2018-06-15
last_seen: 2025-01-21
first_seen_parent: 2018-12-31
last_seen_parent: 2025-05-13
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 491.1, "avg_administrations": 27}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 28 times with a 11.0 weekly interval (308.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Melanoma - PEMBROLIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Melanoma - PEMBROLIZUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £7,154
first_seen: 2021-07-10
last_seen: 2025-07-15
first_seen_parent: 2019-06-20
last_seen_parent: 2025-01-26
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: PEMBROLIZUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 30 times with a 3.8 weekly interval (114.0 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 4 times with a 4.7 weekly interval (18.8 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 383.5, "avg_administrations": 8}, {"drug": "NIVOLUMAB", "avg_dose_mg": 428.2, "avg_administrations": 6}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Melanoma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £12,162
first_seen: 2019-06-02
last_seen: 2024-11-10
first_seen_parent: 2020-01-22
last_seen_parent: 2025-08-06
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 499.7, "avg_administrations": 22}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 29 times with a 9.6 weekly interval (278.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple myeloma - LENALIDOMIDE
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple myeloma - LENALIDOMIDE - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £15,092
first_seen: 2022-07-25
last_seen: 2024-06-12
first_seen_parent: 2019-10-16
last_seen_parent: 2024-03-01
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: LENALIDOMIDE|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 6 times with a 8.0 weekly interval (48.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 19 times with a 7.1 weekly interval (134.9 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 113.9, "avg_administrations": 5}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 345.4, "avg_administrations": 6}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple myeloma - LENALIDOMIDE
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple myeloma - LENALIDOMIDE - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £5,282
first_seen: 2021-11-14
last_seen: 2024-04-18
first_seen_parent: 2019-10-19
last_seen_parent: 2024-08-09
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: LENALIDOMIDE|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 4 times with a 3.6 weekly interval (14.4 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 16 times with a 7.4 weekly interval (118.4 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 448.5, "avg_administrations": 22}, {"drug": "RITUXIMAB", "avg_dose_mg": 137.2, "avg_administrations": 11}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple myeloma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £17,944
first_seen: 2021-12-16
last_seen: 2024-03-18
first_seen_parent: 2018-03-22
last_seen_parent: 2025-08-30
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 82.1, "avg_administrations": 22}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 14 times with a 2.7 weekly interval (37.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £8,857
first_seen: 2022-09-05
last_seen: 2024-04-18
first_seen_parent: 2020-07-17
last_seen_parent: 2024-03-13
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: OCRELIZUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 25 times with a 2.7 weekly interval (67.5 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 13 times with a 6.9 weekly interval (89.7 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 410.4, "avg_administrations": 30}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 487.2, "avg_administrations": 21}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £15,053
first_seen: 2019-06-09
last_seen: 2025-09-14
first_seen_parent: 2018-08-09
last_seen_parent: 2025-02-10
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 91.2, "avg_administrations": 27}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 27 times with a 9.3 weekly interval (251.1 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £27,219
first_seen: 2020-06-24
last_seen: 2025-12-18
first_seen_parent: 2017-03-17
last_seen_parent: 2024-03-31
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 459.7, "avg_administrations": 29}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 6 times with a 6.4 weekly interval (38.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-Hodgkin lymphoma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £9,467
first_seen: 2019-06-19
last_seen: 2025-11-10
first_seen_parent: 2019-02-13
last_seen_parent: 2025-08-22
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 356.8, "avg_administrations": 16}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 16 times with a 11.9 weekly interval (190.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £7,774
first_seen: 2019-10-10
last_seen: 2025-03-27
first_seen_parent: 2018-07-20
last_seen_parent: 2025-12-04
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 251.1, "avg_administrations": 30}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 21 times with a 5.0 weekly interval (105.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £17,240
first_seen: 2018-01-31
last_seen: 2024-12-19
first_seen_parent: 2017-12-12
last_seen_parent: 2025-01-24
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 196.4, "avg_administrations": 20}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 28 times with a 2.3 weekly interval (64.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £11,566
first_seen: 2018-02-24
last_seen: 2024-09-01
first_seen_parent: 2017-02-06
last_seen_parent: 2025-06-05
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 286.2, "avg_administrations": 25}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 4 times with a 2.6 weekly interval (10.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £10,073
first_seen: 2020-01-19
last_seen: 2025-07-20
first_seen_parent: 2019-12-05
last_seen_parent: 2025-10-09
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 158.9, "avg_administrations": 8}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 12 times with a 11.9 weekly interval (142.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £22,302
first_seen: 2021-07-16
last_seen: 2024-02-05
first_seen_parent: 2018-11-01
last_seen_parent: 2024-12-27
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 363.3, "avg_administrations": 22}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 25 times with a 10.3 weekly interval (257.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £27,616
first_seen: 2021-09-08
last_seen: 2024-10-19
first_seen_parent: 2019-05-29
last_seen_parent: 2024-08-01
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 366.8, "avg_administrations": 19}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 26 times with a 11.9 weekly interval (309.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £7,362
first_seen: 2018-12-31
last_seen: 2024-11-02
first_seen_parent: 2020-11-20
last_seen_parent: 2024-11-11
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 494.4, "avg_administrations": 16}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 22 times with a 6.9 weekly interval (151.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £19,090
first_seen: 2019-08-09
last_seen: 2025-06-25
first_seen_parent: 2018-04-28
last_seen_parent: 2024-12-30
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 8 times with a 5.7 weekly interval (45.6 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 19 times with a 6.6 weekly interval (125.4 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 276.4, "avg_administrations": 22}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 181.4, "avg_administrations": 16}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £8,766
first_seen: 2018-04-20
last_seen: 2024-08-04
first_seen_parent: 2019-06-11
last_seen_parent: 2024-12-16
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 458.1, "avg_administrations": 6}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 16 times with a 11.1 weekly interval (177.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £20,382
first_seen: 2021-04-01
last_seen: 2024-03-20
first_seen_parent: 2018-08-16
last_seen_parent: 2024-06-14
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NIVOLUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 16 times with a 11.6 weekly interval (185.6 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 8 times with a 7.9 weekly interval (63.2 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 377.8, "avg_administrations": 15}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 280.9, "avg_administrations": 4}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Renal cell carcinoma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £26,567
first_seen: 2019-01-05
last_seen: 2024-04-15
first_seen_parent: 2019-07-27
last_seen_parent: 2025-10-30
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 244.8, "avg_administrations": 9}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 9 times with a 5.9 weekly interval (53.1 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £13,858
first_seen: 2020-08-11
last_seen: 2025-10-12
first_seen_parent: 2017-07-03
last_seen_parent: 2025-10-19
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 118.4, "avg_administrations": 23}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 24 times with a 7.0 weekly interval (168.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £21,036
first_seen: 2019-10-28
last_seen: 2024-09-21
first_seen_parent: 2017-06-04
last_seen_parent: 2024-08-10
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 170.5, "avg_administrations": 14}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 15 times with a 2.5 weekly interval (37.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ADALIMUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £5,160
first_seen: 2019-09-06
last_seen: 2024-12-28
first_seen_parent: 2018-01-31
last_seen_parent: 2024-11-11
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 14 times with a 6.1 weekly interval (85.4 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 16 times with a 4.2 weekly interval (67.2 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 106.7, "avg_administrations": 26}, {"drug": "NIVOLUMAB", "avg_dose_mg": 255.4, "avg_administrations": 15}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ADALIMUMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £14,054
first_seen: 2021-07-11
last_seen: 2025-09-25
first_seen_parent: 2021-07-30
last_seen_parent: 2024-11-22
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6 times with a 6.2 weekly interval (37.2 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 13 times with a 2.3 weekly interval (29.9 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 118.1, "avg_administrations": 12}, {"drug": "BARICITINIB", "avg_dose_mg": 85.7, "avg_administrations": 29}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £18,843
first_seen: 2021-06-06
last_seen: 2025-11-04
first_seen_parent: 2018-01-04
last_seen_parent: 2025-08-20
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 456.7, "avg_administrations": 15}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11 times with a 5.9 weekly interval (64.9 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £9,842
first_seen: 2020-12-18
last_seen: 2024-05-12
first_seen_parent: 2017-05-14
last_seen_parent: 2025-08-30
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 338.7, "avg_administrations": 8}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 16 times with a 4.9 weekly interval (78.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £7,385
first_seen: 2021-09-22
last_seen: 2024-09-20
first_seen_parent: 2019-02-21
last_seen_parent: 2025-11-15
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 294.8, "avg_administrations": 23}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 6 times with a 11.3 weekly interval (67.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - INFLIXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - INFLIXIMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £20,133
first_seen: 2020-09-01
last_seen: 2025-12-09
first_seen_parent: 2021-03-22
last_seen_parent: 2024-03-28
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: INFLIXIMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 23 times with a 4.6 weekly interval (105.8 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 5 times with a 8.2 weekly interval (41.0 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 182.7, "avg_administrations": 14}, {"drug": "ADALIMUMAB", "avg_dose_mg": 107.6, "avg_administrations": 26}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £8,307
first_seen: 2021-11-30
last_seen: 2025-01-05
first_seen_parent: 2020-01-25
last_seen_parent: 2025-07-14
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 424.4, "avg_administrations": 10}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 27 times with a 11.7 weekly interval (315.9 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £11,255
first_seen: 2021-01-01
last_seen: 2025-07-10
first_seen_parent: 2018-09-02
last_seen_parent: 2025-08-16
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 341.0, "avg_administrations": 16}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 29 times with a 3.3 weekly interval (95.7 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £10,833
first_seen: 2019-09-13
last_seen: 2024-02-24
first_seen_parent: 2017-06-01
last_seen_parent: 2024-06-01
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 358.9, "avg_administrations": 15}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 29 times with a 9.1 weekly interval (263.9 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Uveitis - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Uveitis - ADALIMUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £18,110
first_seen: 2022-09-20
last_seen: 2025-01-21
first_seen_parent: 2021-09-02
last_seen_parent: 2024-04-29
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 16 times with a 7.1 weekly interval (113.6 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 19 times with a 9.2 weekly interval (174.8 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 133.2, "avg_administrations": 30}, {"drug": "SECUKINUMAB", "avg_dose_mg": 493.2, "avg_administrations": 18}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Uveitis - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Uveitis - ADALIMUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £12,794
first_seen: 2019-02-06
last_seen: 2024-11-09
first_seen_parent: 2020-11-27
last_seen_parent: 2025-11-30
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 19 times with a 11.4 weekly interval (216.6 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 18 times with a 6.7 weekly interval (120.6 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 70.7, "avg_administrations": 13}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 353.4, "avg_administrations": 25}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Uveitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £16,611
first_seen: 2018-10-04
last_seen: 2024-09-22
first_seen_parent: 2019-11-14
last_seen_parent: 2025-12-19
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 429.6, "avg_administrations": 27}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 20 times with a 11.7 weekly interval (234.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - AFLIBERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - AFLIBERCEPT - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £11,960
first_seen: 2021-08-01
last_seen: 2025-06-25
first_seen_parent: 2020-06-13
last_seen_parent: 2024-10-05
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: AFLIBERCEPT|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 18 times with a 5.4 weekly interval (97.2 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 25 times with a 7.7 weekly interval (192.5 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 67.1, "avg_administrations": 29}, {"drug": "RITUXIMAB", "avg_dose_mg": 76.7, "avg_administrations": 10}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - AFLIBERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - AFLIBERCEPT - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £10,438
first_seen: 2019-06-07
last_seen: 2025-12-13
first_seen_parent: 2018-08-16
last_seen_parent: 2025-04-20
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: AFLIBERCEPT|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 22 times with a 10.3 weekly interval (226.6 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 6 times with a 4.7 weekly interval (28.2 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 330.6, "avg_administrations": 6}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 92.6, "avg_administrations": 14}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £14,014
first_seen: 2018-07-24
last_seen: 2024-04-14
first_seen_parent: 2019-08-19
last_seen_parent: 2025-06-17
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 493.4, "avg_administrations": 16}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 23 times with a 5.4 weekly interval (124.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - RANIBIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - RANIBIZUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £13,894
first_seen: 2022-10-22
last_seen: 2025-03-30
first_seen_parent: 2020-07-22
last_seen_parent: 2025-09-19
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RANIBIZUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 23 times with a 9.6 weekly interval (220.8 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 9 times with a 3.1 weekly interval (27.9 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 188.4, "avg_administrations": 26}, {"drug": "SECUKINUMAB", "avg_dose_mg": 301.0, "avg_administrations": 6}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - RANIBIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - RANIBIZUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £11,237
first_seen: 2019-06-06
last_seen: 2024-04-17
first_seen_parent: 2019-11-26
last_seen_parent: 2024-02-26
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RANIBIZUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 4 times with a 4.0 weekly interval (16.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 25 times with a 2.1 weekly interval (52.5 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 391.5, "avg_administrations": 28}, {"drug": "RITUXIMAB", "avg_dose_mg": 54.7, "avg_administrations": 10}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £20,754
first_seen: 2018-11-30
last_seen: 2025-11-03
first_seen_parent: 2017-12-23
last_seen_parent: 2024-04-24
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 436.9, "avg_administrations": 30}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 29 times with a 2.5 weekly interval (72.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £7,734
first_seen: 2019-04-19
last_seen: 2025-08-04
first_seen_parent: 2018-03-14
last_seen_parent: 2024-12-31
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 95.4, "avg_administrations": 26}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 12 times with a 2.5 weekly interval (30.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £29,447
first_seen: 2021-12-06
last_seen: 2024-04-29
first_seen_parent: 2019-06-21
last_seen_parent: 2024-11-08
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 212.5, "avg_administrations": 30}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 19 times with a 3.2 weekly interval (60.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Atopic dermatitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £10,483
first_seen: 2021-12-17
last_seen: 2024-01-08
first_seen_parent: 2017-07-08
last_seen_parent: 2025-01-02
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 413.8, "avg_administrations": 17}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 20 times with a 10.5 weekly interval (210.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £23,233
first_seen: 2019-10-21
last_seen: 2025-04-15
first_seen_parent: 2020-11-20
last_seen_parent: 2025-11-20
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 364.0, "avg_administrations": 5}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 10 times with a 7.3 weekly interval (73.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £16,019
first_seen: 2019-01-03
last_seen: 2024-08-18
first_seen_parent: 2018-09-12
last_seen_parent: 2025-06-09
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 272.6, "avg_administrations": 17}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 30 times with a 3.5 weekly interval (105.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Colorectal cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £23,072
first_seen: 2019-04-04
last_seen: 2025-04-11
first_seen_parent: 2020-04-05
last_seen_parent: 2025-11-13
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 299.7, "avg_administrations": 24}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 10 times with a 3.9 weekly interval (39.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £14,594
first_seen: 2019-07-26
last_seen: 2025-05-09
first_seen_parent: 2017-03-12
last_seen_parent: 2024-05-26
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 432.2, "avg_administrations": 21}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 19 times with a 8.1 weekly interval (153.9 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - ADALIMUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £15,020
first_seen: 2019-10-13
last_seen: 2024-01-18
first_seen_parent: 2018-04-07
last_seen_parent: 2025-04-25
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 15 times with a 3.4 weekly interval (51.0 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 18 times with a 6.8 weekly interval (122.4 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 96.1, "avg_administrations": 27}, {"drug": "IBRUTINIB", "avg_dose_mg": 64.3, "avg_administrations": 19}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - ADALIMUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £10,542
first_seen: 2021-04-02
last_seen: 2024-09-16
first_seen_parent: 2018-05-09
last_seen_parent: 2025-04-15
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 19 times with a 10.3 weekly interval (195.7 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 13 times with a 4.9 weekly interval (63.7 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 373.8, "avg_administrations": 27}, {"drug": "TOFACITINIB", "avg_dose_mg": 356.2, "avg_administrations": 6}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £19,641
first_seen: 2021-02-21
last_seen: 2025-04-13
first_seen_parent: 2017-06-17
last_seen_parent: 2025-11-11
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 88.7, "avg_administrations": 4}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 28 times with a 9.0 weekly interval (252.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - VEDOLIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - VEDOLIZUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £11,012
first_seen: 2019-05-28
last_seen: 2025-10-21
first_seen_parent: 2020-08-26
last_seen_parent: 2024-08-26
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: VEDOLIZUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 22 times with a 5.8 weekly interval (127.6 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 28 times with a 5.7 weekly interval (159.6 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 276.4, "avg_administrations": 13}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 130.7, "avg_administrations": 30}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - VEDOLIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - VEDOLIZUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £15,278
first_seen: 2019-06-14
last_seen: 2025-12-28
first_seen_parent: 2021-07-20
last_seen_parent: 2025-02-27
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: VEDOLIZUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 15 times with a 10.2 weekly interval (153.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 15 times with a 8.6 weekly interval (129.0 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 165.3, "avg_administrations": 4}, {"drug": "ETANERCEPT", "avg_dose_mg": 345.9, "avg_administrations": 30}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £15,319
first_seen: 2021-11-21
last_seen: 2024-02-29
first_seen_parent: 2017-12-10
last_seen_parent: 2025-12-26
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 308.4, "avg_administrations": 30}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 18 times with a 2.6 weekly interval (46.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Diabetic macular oedema - AFLIBERCEPT
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Diabetic macular oedema - AFLIBERCEPT - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £10,604
first_seen: 2021-04-03
last_seen: 2025-07-22
first_seen_parent: 2021-06-06
last_seen_parent: 2025-12-06
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: AFLIBERCEPT|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 23 times with a 7.2 weekly interval (165.6 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 27 times with a 11.2 weekly interval (302.4 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 449.7, "avg_administrations": 18}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 473.8, "avg_administrations": 24}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Diabetic macular oedema
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £18,893
first_seen: 2021-04-07
last_seen: 2024-08-28
first_seen_parent: 2017-07-01
last_seen_parent: 2025-09-11
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 86.6, "avg_administrations": 18}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 4 times with a 7.1 weekly interval (28.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Giant cell arteritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £19,690
first_seen: 2018-12-31
last_seen: 2025-08-12
first_seen_parent: 2018-02-28
last_seen_parent: 2024-07-03
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 280.8, "avg_administrations": 22}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 5 times with a 9.8 weekly interval (49.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HER2+ breast cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £21,034
first_seen: 2021-10-07
last_seen: 2025-08-31
first_seen_parent: 2018-02-06
last_seen_parent: 2025-11-16
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 386.3, "avg_administrations": 29}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 12 times with a 11.4 weekly interval (136.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Mantle cell lymphoma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £8,299
first_seen: 2021-09-12
last_seen: 2024-12-25
first_seen_parent: 2017-02-15
last_seen_parent: 2025-07-29
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 218.4, "avg_administrations": 21}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 27 times with a 3.3 weekly interval (89.1 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Melanoma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £5,247
first_seen: 2021-10-31
last_seen: 2024-04-27
first_seen_parent: 2020-05-28
last_seen_parent: 2025-01-26
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 329.2, "avg_administrations": 17}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 25 times with a 3.3 weekly interval (82.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple myeloma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £7,873
first_seen: 2021-03-10
last_seen: 2024-05-13
first_seen_parent: 2019-10-14
last_seen_parent: 2025-03-03
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 294.9, "avg_administrations": 23}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 11 times with a 2.4 weekly interval (26.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - OCRELIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - OCRELIZUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £10,784
first_seen: 2021-10-31
last_seen: 2024-07-14
first_seen_parent: 2020-01-11
last_seen_parent: 2025-03-12
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: OCRELIZUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 22 times with a 10.8 weekly interval (237.6 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 19 times with a 8.4 weekly interval (159.6 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 346.9, "avg_administrations": 23}, {"drug": "NIVOLUMAB", "avg_dose_mg": 228.2, "avg_administrations": 24}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - OCRELIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - OCRELIZUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £7,310
first_seen: 2019-04-10
last_seen: 2025-03-05
first_seen_parent: 2019-08-21
last_seen_parent: 2024-08-14
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: OCRELIZUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 17 times with a 9.2 weekly interval (156.4 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 4 times with a 2.6 weekly interval (10.4 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 333.5, "avg_administrations": 14}, {"drug": "RITUXIMAB", "avg_dose_mg": 206.8, "avg_administrations": 10}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £4,630
first_seen: 2018-08-27
last_seen: 2025-02-10
first_seen_parent: 2018-11-30
last_seen_parent: 2025-12-08
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 234.8, "avg_administrations": 9}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 13 times with a 7.8 weekly interval (101.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £13,495
first_seen: 2021-07-09
last_seen: 2024-09-13
first_seen_parent: 2018-03-11
last_seen_parent: 2025-08-03
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 157.1, "avg_administrations": 18}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 16 times with a 6.5 weekly interval (104.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-Hodgkin lymphoma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £11,203
first_seen: 2019-03-07
last_seen: 2025-08-14
first_seen_parent: 2020-08-23
last_seen_parent: 2024-01-24
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 201.4, "avg_administrations": 18}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 9 times with a 3.7 weekly interval (33.3 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: AFLIBERCEPT
cost_pp_pa: £17,632
first_seen: 2019-06-09
last_seen: 2025-03-29
first_seen_parent: 2019-01-12
last_seen_parent: 2025-10-08
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: PEMBROLIZUMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB - AFLIBERCEPT

average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 26 times with a 3.9 weekly interval (101.4 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 23 times with a 7.3 weekly interval (167.9 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 415.8, "avg_administrations": 11}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 408.8, "avg_administrations": 21}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £13,727
first_seen: 2021-08-29
last_seen: 2024-04-18
first_seen_parent: 2020-11-23
last_seen_parent: 2024-10-05
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: PEMBROLIZUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB - VEDOLIZUMAB

average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 22 times with a 10.4 weekly interval (228.8 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 29 times with a 3.3 weekly interval (95.7 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 257.3, "avg_administrations": 8}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 424.7, "avg_administrations": 14}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £3,992
first_seen: 2019-03-07
last_seen: 2024-11-16
first_seen_parent: 2019-01-18
last_seen_parent: 2025-03-20
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 131.8, "avg_administrations": 22}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 19 times with a 8.2 weekly interval (155.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - NIVOLUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - NIVOLUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £9,829
first_seen: 2020-05-09
last_seen: 2024-12-24
first_seen_parent: 2019-04-30
last_seen_parent: 2024-03-21
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NIVOLUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 11 times with a 11.3 weekly interval (124.3 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 7 times with a 5.0 weekly interval (35.0 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 134.6, "avg_administrations": 11}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 449.8, "avg_administrations": 20}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £6,318
first_seen: 2019-07-08
last_seen: 2024-09-14
first_seen_parent: 2019-04-30
last_seen_parent: 2025-09-07
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 325.9, "avg_administrations": 19}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 19 times with a 6.3 weekly interval (119.7 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: USTEKINUMAB
cost_pp_pa: £6,684
first_seen: 2022-12-15
last_seen: 2024-03-24
first_seen_parent: 2019-01-16
last_seen_parent: 2025-04-26
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BEVACIZUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - BEVACIZUMAB - USTEKINUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 22 times with a 12.0 weekly interval (264.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 21 times with a 9.3 weekly interval (195.3 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 107.5, "avg_administrations": 24}, {"drug": "USTEKINUMAB", "avg_dose_mg": 230.5, "avg_administrations": 19}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £17,952
first_seen: 2018-11-30
last_seen: 2024-04-15
first_seen_parent: 2020-06-05
last_seen_parent: 2024-03-18
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 245.7, "avg_administrations": 16}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 20 times with a 10.9 weekly interval (218.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - ADALIMUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £7,877
first_seen: 2020-02-27
last_seen: 2024-11-01
first_seen_parent: 2019-11-30
last_seen_parent: 2024-08-07
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9 times with a 4.2 weekly interval (37.8 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 28 times with a 2.8 weekly interval (78.4 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 191.5, "avg_administrations": 16}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 345.0, "avg_administrations": 19}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £5,232
first_seen: 2019-09-19
last_seen: 2024-09-30
first_seen_parent: 2017-11-30
last_seen_parent: 2025-01-14
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 148.5, "avg_administrations": 22}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6 times with a 8.1 weekly interval (48.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £11,535
first_seen: 2018-12-09
last_seen: 2025-07-01
first_seen_parent: 2020-05-29
last_seen_parent: 2025-01-16
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 492.0, "avg_administrations": 11}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 18 times with a 10.8 weekly interval (194.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £16,127
first_seen: 2020-12-02
last_seen: 2025-08-25
first_seen_parent: 2020-10-08
last_seen_parent: 2025-02-25
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 348.8, "avg_administrations": 23}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 15 times with a 10.9 weekly interval (163.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £20,749
first_seen: 2018-01-21
last_seen: 2025-06-08
first_seen_parent: 2020-12-09
last_seen_parent: 2024-04-17
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 336.4, "avg_administrations": 4}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 25 times with a 9.7 weekly interval (242.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £11,631
first_seen: 2021-10-05
last_seen: 2024-05-01
first_seen_parent: 2018-01-20
last_seen_parent: 2024-04-30
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 130.2, "avg_administrations": 29}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 28 times with a 3.4 weekly interval (95.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Renal cell carcinoma - NIVOLUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Renal cell carcinoma - NIVOLUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £12,947
first_seen: 2020-12-18
last_seen: 2024-03-23
first_seen_parent: 2020-11-17
last_seen_parent: 2025-10-08
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NIVOLUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 12 times with a 10.9 weekly interval (130.8 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 13 times with a 4.0 weekly interval (52.0 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 441.3, "avg_administrations": 12}, {"drug": "NATALIZUMAB", "avg_dose_mg": 138.8, "avg_administrations": 21}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Renal cell carcinoma - NIVOLUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Renal cell carcinoma - NIVOLUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £13,282
first_seen: 2022-09-08
last_seen: 2025-02-08
first_seen_parent: 2020-07-22
last_seen_parent: 2024-06-05
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NIVOLUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 20 times with a 5.9 weekly interval (118.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 21 times with a 6.5 weekly interval (136.5 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 126.7, "avg_administrations": 12}, {"drug": "RITUXIMAB", "avg_dose_mg": 124.9, "avg_administrations": 6}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Renal cell carcinoma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £8,077
first_seen: 2018-08-16
last_seen: 2025-10-28
first_seen_parent: 2020-06-09
last_seen_parent: 2025-04-04
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 227.4, "avg_administrations": 17}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 23 times with a 10.0 weekly interval (230.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - TOFACITINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - TOFACITINIB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £4,403
first_seen: 2019-09-05
last_seen: 2025-08-20
first_seen_parent: 2018-07-14
last_seen_parent: 2024-09-27
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOFACITINIB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 18 times with a 3.2 weekly interval (57.6 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 30 times with a 9.0 weekly interval (270.0 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 474.8, "avg_administrations": 24}, {"drug": "ETANERCEPT", "avg_dose_mg": 456.2, "avg_administrations": 25}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - TOFACITINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - TOFACITINIB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £18,463
first_seen: 2019-09-19
last_seen: 2024-12-24
first_seen_parent: 2019-10-23
last_seen_parent: 2025-08-21
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOFACITINIB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 17 times with a 3.3 weekly interval (56.1 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 21 times with a 9.7 weekly interval (203.7 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 102.3, "avg_administrations": 6}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 105.9, "avg_administrations": 18}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £18,939
first_seen: 2018-12-10
last_seen: 2025-10-31
first_seen_parent: 2017-03-30
last_seen_parent: 2025-09-03
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 50.4, "avg_administrations": 24}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 12 times with a 4.8 weekly interval (57.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £19,859
first_seen: 2018-05-25
last_seen: 2024-07-21
first_seen_parent: 2019-10-21
last_seen_parent: 2025-04-14
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 61.5, "avg_administrations": 21}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8 times with a 7.1 weekly interval (56.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £10,790
first_seen: 2019-02-25
last_seen: 2025-10-08
first_seen_parent: 2018-03-28
last_seen_parent: 2024-06-08
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 85.8, "avg_administrations": 18}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 17 times with a 3.7 weekly interval (62.9 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £12,215
first_seen: 2018-11-21
last_seen: 2025-03-14
first_seen_parent: 2020-12-28
last_seen_parent: 2025-03-26
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 498.1, "avg_administrations": 16}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 15 times with a 3.6 weekly interval (54.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £3,162
first_seen: 2018-08-24
last_seen: 2025-06-27
first_seen_parent: 2019-05-13
last_seen_parent: 2024-11-13
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 124.7, "avg_administrations": 16}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 28 times with a 7.0 weekly interval (196.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £5,803
first_seen: 2019-01-20
last_seen: 2024-12-24
first_seen_parent: 2017-01-14
last_seen_parent: 2024-04-23
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 135.0, "avg_administrations": 5}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 5 times with a 11.7 weekly interval (58.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £15,468
first_seen: 2018-05-22
last_seen: 2024-02-04
first_seen_parent: 2017-08-15
last_seen_parent: 2024-07-12
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 181.1, "avg_administrations": 11}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 29 times with a 2.1 weekly interval (60.9 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Uveitis - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Uveitis - ADALIMUMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £17,590
first_seen: 2019-01-05
last_seen: 2024-04-27
first_seen_parent: 2020-09-02
last_seen_parent: 2025-02-19
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 15 times with a 2.9 weekly interval (43.5 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 20 times with a 2.2 weekly interval (44.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 303.2, "avg_administrations": 26}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 315.9, "avg_administrations": 11}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Uveitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £19,835
first_seen: 2021-04-27
last_seen: 2025-08-29
first_seen_parent: 2019-12-30
last_seen_parent: 2024-09-06
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 349.7, "avg_administrations": 10}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4 times with a 3.2 weekly interval (12.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £22,495
first_seen: 2018-08-13
last_seen: 2025-12-11
first_seen_parent: 2017-01-01
last_seen_parent: 2025-06-02
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 185.8, "avg_administrations": 19}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 10 times with a 4.6 weekly interval (46.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD - RANIBIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD - RANIBIZUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £5,313
first_seen: 2020-05-04
last_seen: 2024-12-21
first_seen_parent: 2018-11-07
last_seen_parent: 2024-01-09
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RANIBIZUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 24 times with a 5.5 weekly interval (132.0 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 12 times with a 7.7 weekly interval (92.4 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 230.3, "avg_administrations": 13}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 164.2, "avg_administrations": 17}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £7,311
first_seen: 2019-02-20
last_seen: 2025-03-05
first_seen_parent: 2020-05-15
last_seen_parent: 2024-11-14
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 401.3, "avg_administrations": 6}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 24 times with a 5.7 weekly interval (136.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - ETANERCEPT
labels: SECUKINUMAB
cost_pp_pa: £9,853
first_seen: 2019-10-11
last_seen: 2024-12-16
first_seen_parent: 2019-05-01
last_seen_parent: 2024-07-19
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ETANERCEPT|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - ETANERCEPT - SECUKINUMAB

average_spacing:
<br><b>ETANERCEPT</b><br>On average given 10 times with a 8.4 weekly interval (84.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 9 times with a 8.4 weekly interval (75.6 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 131.2, "avg_administrations": 25}, {"drug": "SECUKINUMAB", "avg_dose_mg": 51.9, "avg_administrations": 17}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £20,871
first_seen: 2018-10-07
last_seen: 2025-12-16
first_seen_parent: 2019-09-02
last_seen_parent: 2025-12-21
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 418.1, "avg_administrations": 10}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 9 times with a 8.4 weekly interval (75.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB
labels: LENALIDOMIDE
cost_pp_pa: £16,674
first_seen: 2019-06-16
last_seen: 2024-06-10
first_seen_parent: 2019-02-06
last_seen_parent: 2025-12-15
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB - LENALIDOMIDE

average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 5 times with a 9.4 weekly interval (47.0 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 22 times with a 11.5 weekly interval (253.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 456.6, "avg_administrations": 19}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 360.3, "avg_administrations": 30}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £15,067
first_seen: 2020-10-08
last_seen: 2024-03-30
first_seen_parent: 2021-04-24
last_seen_parent: 2025-05-10
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB - PEMBROLIZUMAB

average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 11 times with a 3.4 weekly interval (37.4 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 19 times with a 10.8 weekly interval (205.2 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 195.1, "avg_administrations": 20}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 316.9, "avg_administrations": 5}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £20,486
first_seen: 2019-12-14
last_seen: 2025-09-21
first_seen_parent: 2020-06-06
last_seen_parent: 2025-02-19
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 50.2, "avg_administrations": 20}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 10 times with a 11.1 weekly interval (111.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Atopic dermatitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £14,280
first_seen: 2021-09-21
last_seen: 2025-05-16
first_seen_parent: 2017-12-18
last_seen_parent: 2024-01-03
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 204.4, "avg_administrations": 5}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 12 times with a 11.5 weekly interval (138.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £20,999
first_seen: 2019-02-15
last_seen: 2024-08-28
first_seen_parent: 2020-11-03
last_seen_parent: 2025-09-12
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 299.6, "avg_administrations": 28}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 25 times with a 11.6 weekly interval (290.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £15,149
first_seen: 2021-12-24
last_seen: 2024-04-21
first_seen_parent: 2020-08-04
last_seen_parent: 2025-05-19
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 214.1, "avg_administrations": 18}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 29 times with a 9.8 weekly interval (284.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Colorectal cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £27,727
first_seen: 2019-03-14
last_seen: 2024-06-12
first_seen_parent: 2019-08-22
last_seen_parent: 2024-02-06
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 68.2, "avg_administrations": 30}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 5 times with a 4.0 weekly interval (20.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £4,024
first_seen: 2018-11-10
last_seen: 2024-08-23
first_seen_parent: 2019-11-01
last_seen_parent: 2024-10-16
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 165.3, "avg_administrations": 20}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 21 times with a 4.5 weekly interval (94.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - USTEKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - USTEKINUMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £6,043
first_seen: 2019-11-01
last_seen: 2024-03-23
first_seen_parent: 2018-02-06
last_seen_parent: 2025-11-03
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: USTEKINUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 20 times with a 2.4 weekly interval (48.0 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 16 times with a 10.7 weekly interval (171.2 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 91.9, "avg_administrations": 19}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 143.0, "avg_administrations": 14}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - USTEKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - USTEKINUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £7,633
first_seen: 2020-09-06
last_seen: 2024-01-02
first_seen_parent: 2020-12-14
last_seen_parent: 2025-09-18
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: USTEKINUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 18 times with a 6.4 weekly interval (115.2 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 15 times with a 9.5 weekly interval (142.5 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 309.6, "avg_administrations": 5}, {"drug": "NATALIZUMAB", "avg_dose_mg": 231.0, "avg_administrations": 22}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £11,463
first_seen: 2019-06-18
last_seen: 2025-01-24
first_seen_parent: 2020-01-22
last_seen_parent: 2024-03-23
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 206.6, "avg_administrations": 28}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 10 times with a 9.8 weekly interval (98.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Diabetic macular oedema
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £2,724
first_seen: 2020-12-02
last_seen: 2024-06-20
first_seen_parent: 2017-06-14
last_seen_parent: 2024-02-25
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 369.2, "avg_administrations": 18}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 13 times with a 10.1 weekly interval (131.3 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £4,436
first_seen: 2022-05-15
last_seen: 2024-09-16
first_seen_parent: 2019-06-28
last_seen_parent: 2024-07-09
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOCILIZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 12 times with a 2.7 weekly interval (32.4 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 19 times with a 7.6 weekly interval (144.4 weeks total treatment length)

average_administered:
[{"drug": "TOCILIZUMAB", "avg_dose_mg": 499.6, "avg_administrations": 19}, {"drug": "TOFACITINIB", "avg_dose_mg": 65.0, "avg_administrations": 14}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £5,823
first_seen: 2021-12-27
last_seen: 2025-03-02
first_seen_parent: 2019-06-24
last_seen_parent: 2024-01-04
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOCILIZUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 25 times with a 7.9 weekly interval (197.5 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 9 times with a 11.0 weekly interval (99.0 weeks total treatment length)

average_administered:
[{"drug": "TOCILIZUMAB", "avg_dose_mg": 442.2, "avg_administrations": 6}, {"drug": "RITUXIMAB", "avg_dose_mg": 426.2, "avg_administrations": 4}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Giant cell arteritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £5,480
first_seen: 2019-12-26
last_seen: 2025-05-18
first_seen_parent: 2017-10-11
last_seen_parent: 2025-05-25
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 201.9, "avg_administrations": 21}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 19 times with a 5.0 weekly interval (95.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £17,430
first_seen: 2021-11-12
last_seen: 2025-06-09
first_seen_parent: 2020-10-25
last_seen_parent: 2024-10-29
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TRASTUZUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 30 times with a 2.0 weekly interval (60.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 5 times with a 8.2 weekly interval (41.0 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 149.6, "avg_administrations": 24}, {"drug": "ETANERCEPT", "avg_dose_mg": 497.6, "avg_administrations": 21}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HER2+ breast cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £11,729
first_seen: 2018-11-02
last_seen: 2024-03-24
first_seen_parent: 2017-09-15
last_seen_parent: 2024-12-14
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 87.8, "avg_administrations": 25}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 26 times with a 3.3 weekly interval (85.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Mantle cell lymphoma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £12,587
first_seen: 2018-02-13
last_seen: 2024-08-18
first_seen_parent: 2018-07-17
last_seen_parent: 2024-05-18
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 72.3, "avg_administrations": 18}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 9 times with a 4.2 weekly interval (37.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Melanoma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £15,029
first_seen: 2021-08-25
last_seen: 2025-03-10
first_seen_parent: 2017-04-22
last_seen_parent: 2025-07-31
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 76.6, "avg_administrations": 18}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 6 times with a 2.5 weekly interval (15.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple myeloma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £4,003
first_seen: 2020-09-05
last_seen: 2024-02-23
first_seen_parent: 2020-06-12
last_seen_parent: 2025-04-26
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 61.6, "avg_administrations": 15}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 21 times with a 11.4 weekly interval (239.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £11,613
first_seen: 2020-10-10
last_seen: 2024-04-23
first_seen_parent: 2017-07-17
last_seen_parent: 2024-03-23
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 123.0, "avg_administrations": 28}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 28 times with a 10.2 weekly interval (285.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £27,028
first_seen: 2019-06-26
last_seen: 2024-11-06
first_seen_parent: 2019-01-21
last_seen_parent: 2024-09-06
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 66.0, "avg_administrations": 6}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 22 times with a 10.3 weekly interval (226.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-Hodgkin lymphoma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £7,142
first_seen: 2021-08-05
last_seen: 2025-06-18
first_seen_parent: 2020-03-09
last_seen_parent: 2025-09-18
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 217.7, "avg_administrations": 13}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 24 times with a 7.4 weekly interval (177.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £18,700
first_seen: 2019-09-21
last_seen: 2025-10-15
first_seen_parent: 2020-08-11
last_seen_parent: 2025-06-04
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 235.4, "avg_administrations": 11}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 19 times with a 2.4 weekly interval (45.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB
labels: TOCILIZUMAB
cost_pp_pa: £11,968
first_seen: 2020-06-19
last_seen: 2025-02-21
first_seen_parent: 2021-04-03
last_seen_parent: 2025-01-06
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB - TOCILIZUMAB

average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 12 times with a 4.5 weekly interval (54.0 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 26 times with a 9.8 weekly interval (254.8 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 379.8, "avg_administrations": 6}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 96.1, "avg_administrations": 12}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £19,560
first_seen: 2020-05-11
last_seen: 2025-06-20
first_seen_parent: 2017-01-04
last_seen_parent: 2024-12-25
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 291.4, "avg_administrations": 19}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 20 times with a 4.1 weekly interval (82.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £10,913
first_seen: 2021-03-07
last_seen: 2025-08-27
first_seen_parent: 2020-01-31
last_seen_parent: 2025-09-20
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 276.0, "avg_administrations": 9}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 8 times with a 11.6 weekly interval (92.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - ADALIMUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - ADALIMUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £9,878
first_seen: 2022-09-04
last_seen: 2024-06-18
first_seen_parent: 2021-09-13
last_seen_parent: 2025-10-26
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 18 times with a 10.4 weekly interval (187.2 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 28 times with a 5.6 weekly interval (156.8 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 398.6, "avg_administrations": 23}, {"drug": "NATALIZUMAB", "avg_dose_mg": 370.8, "avg_administrations": 12}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £21,030
first_seen: 2019-09-19
last_seen: 2025-01-22
first_seen_parent: 2018-05-28
last_seen_parent: 2024-12-18
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 254.7, "avg_administrations": 13}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 27 times with a 3.6 weekly interval (97.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - SECUKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - SECUKINUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £11,377
first_seen: 2022-08-15
last_seen: 2025-03-30
first_seen_parent: 2021-10-06
last_seen_parent: 2025-06-30
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 12 times with a 8.2 weekly interval (98.4 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 14 times with a 7.0 weekly interval (98.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 416.1, "avg_administrations": 4}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 262.3, "avg_administrations": 20}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - SECUKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - SECUKINUMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £5,322
first_seen: 2019-08-17
last_seen: 2025-07-26
first_seen_parent: 2021-01-25
last_seen_parent: 2025-04-14
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 18 times with a 8.0 weekly interval (144.0 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 30 times with a 3.6 weekly interval (108.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 337.9, "avg_administrations": 7}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 222.2, "avg_administrations": 27}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £14,347
first_seen: 2018-02-04
last_seen: 2024-05-11
first_seen_parent: 2020-03-06
last_seen_parent: 2025-07-31
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 272.9, "avg_administrations": 28}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 21 times with a 8.1 weekly interval (170.1 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £22,213
first_seen: 2020-12-16
last_seen: 2025-07-30
first_seen_parent: 2018-09-21
last_seen_parent: 2024-09-01
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 144.7, "avg_administrations": 22}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 12 times with a 10.1 weekly interval (121.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £10,274
first_seen: 2018-01-02
last_seen: 2024-07-01
first_seen_parent: 2019-05-06
last_seen_parent: 2024-02-23
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 256.7, "avg_administrations": 13}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 24 times with a 6.4 weekly interval (153.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £11,501
first_seen: 2022-04-20
last_seen: 2024-11-27
first_seen_parent: 2020-03-15
last_seen_parent: 2024-03-27
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 27 times with a 2.7 weekly interval (72.9 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 17 times with a 6.2 weekly interval (105.4 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 473.1, "avg_administrations": 28}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 163.6, "avg_administrations": 27}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £7,064
first_seen: 2019-02-10
last_seen: 2025-01-02
first_seen_parent: 2019-10-27
last_seen_parent: 2025-04-24
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 21 times with a 10.8 weekly interval (226.8 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 10 times with a 6.5 weekly interval (65.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 435.6, "avg_administrations": 20}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 379.3, "avg_administrations": 15}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £6,278
first_seen: 2018-03-03
last_seen: 2024-11-08
first_seen_parent: 2019-08-12
last_seen_parent: 2024-09-08
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 368.0, "avg_administrations": 11}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 28 times with a 8.6 weekly interval (240.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £25,941
first_seen: 2021-11-20
last_seen: 2025-05-05
first_seen_parent: 2017-08-08
last_seen_parent: 2024-07-02
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 473.5, "avg_administrations": 11}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 5 times with a 4.3 weekly interval (21.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £18,019
first_seen: 2022-12-04
last_seen: 2025-02-27
first_seen_parent: 2021-09-04
last_seen_parent: 2025-10-25
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RITUXIMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 26 times with a 8.5 weekly interval (221.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 21 times with a 8.7 weekly interval (182.7 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 58.1, "avg_administrations": 6}, {"drug": "USTEKINUMAB", "avg_dose_mg": 82.3, "avg_administrations": 11}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £12,987
first_seen: 2020-11-21
last_seen: 2024-12-19
first_seen_parent: 2020-11-25
last_seen_parent: 2024-03-12
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 269.0, "avg_administrations": 26}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 15 times with a 11.1 weekly interval (166.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - BARICITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - BARICITINIB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £16,879
first_seen: 2020-01-22
last_seen: 2025-02-14
first_seen_parent: 2020-07-27
last_seen_parent: 2025-02-11
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BARICITINIB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 5 times with a 11.8 weekly interval (59.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 14 times with a 4.1 weekly interval (57.4 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 303.2, "avg_administrations": 20}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 303.6, "avg_administrations": 5}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - BARICITINIB
labels: PEMBROLIZUMAB
cost_pp_pa: £17,827
first_seen: 2019-08-19
last_seen: 2024-06-26
first_seen_parent: 2021-08-28
last_seen_parent: 2024-06-16
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BARICITINIB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - BARICITINIB - PEMBROLIZUMAB

average_spacing:
<br><b>BARICITINIB</b><br>On average given 20 times with a 8.5 weekly interval (170.0 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 7 times with a 9.7 weekly interval (67.9 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 482.9, "avg_administrations": 23}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 89.0, "avg_administrations": 11}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £17,458
first_seen: 2020-11-21
last_seen: 2024-05-06
first_seen_parent: 2020-04-03
last_seen_parent: 2024-12-28
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 309.9, "avg_administrations": 22}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 4 times with a 2.9 weekly interval (11.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - ADALIMUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - ADALIMUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £11,683
first_seen: 2019-01-07
last_seen: 2024-06-19
first_seen_parent: 2021-09-21
last_seen_parent: 2024-07-18
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 18 times with a 6.4 weekly interval (115.2 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 13 times with a 5.6 weekly interval (72.8 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 456.3, "avg_administrations": 10}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 106.9, "avg_administrations": 21}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - ADALIMUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - ADALIMUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £4,977
first_seen: 2020-01-01
last_seen: 2025-05-13
first_seen_parent: 2019-04-26
last_seen_parent: 2025-02-22
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 27 times with a 3.1 weekly interval (83.7 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 8 times with a 9.3 weekly interval (74.4 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 405.8, "avg_administrations": 15}, {"drug": "USTEKINUMAB", "avg_dose_mg": 165.0, "avg_administrations": 10}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £9,734
first_seen: 2018-07-18
last_seen: 2024-09-12
first_seen_parent: 2018-03-14
last_seen_parent: 2024-07-15
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 329.2, "avg_administrations": 28}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 13 times with a 8.7 weekly interval (113.1 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - INFLIXIMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - INFLIXIMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £8,341
first_seen: 2021-07-17
last_seen: 2025-11-18
first_seen_parent: 2020-12-27
last_seen_parent: 2025-03-30
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: INFLIXIMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 14 times with a 4.5 weekly interval (63.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 23 times with a 2.6 weekly interval (59.8 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 135.3, "avg_administrations": 26}, {"drug": "SECUKINUMAB", "avg_dose_mg": 320.1, "avg_administrations": 17}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £11,403
first_seen: 2019-03-03
last_seen: 2024-11-20
first_seen_parent: 2018-01-02
last_seen_parent: 2024-06-12
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 113.3, "avg_administrations": 4}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 10 times with a 10.8 weekly interval (108.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - VEDOLIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - VEDOLIZUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £3,488
first_seen: 2021-09-23
last_seen: 2025-12-17
first_seen_parent: 2021-09-06
last_seen_parent: 2024-06-05
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: VEDOLIZUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 21 times with a 8.6 weekly interval (180.6 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 22 times with a 4.3 weekly interval (94.6 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 370.2, "avg_administrations": 8}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 389.2, "avg_administrations": 10}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £18,439
first_seen: 2018-08-25
last_seen: 2024-03-13
first_seen_parent: 2019-01-02
last_seen_parent: 2024-03-19
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 298.9, "avg_administrations": 11}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 15 times with a 2.1 weekly interval (31.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - TOFACITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - TOFACITINIB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £5,077
first_seen: 2020-12-16
last_seen: 2024-07-01
first_seen_parent: 2018-08-14
last_seen_parent: 2024-08-09
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOFACITINIB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 24 times with a 4.0 weekly interval (96.0 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 20 times with a 4.0 weekly interval (80.0 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 458.9, "avg_administrations": 20}, {"drug": "NIVOLUMAB", "avg_dose_mg": 304.7, "avg_administrations": 15}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - TOFACITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - TOFACITINIB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £3,013
first_seen: 2020-09-24
last_seen: 2024-03-28
first_seen_parent: 2019-06-19
last_seen_parent: 2024-08-18
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOFACITINIB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 19 times with a 11.9 weekly interval (226.1 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 14 times with a 6.3 weekly interval (88.2 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 198.7, "avg_administrations": 7}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 360.4, "avg_administrations": 25}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £4,631
first_seen: 2021-11-03
last_seen: 2024-03-16
first_seen_parent: 2017-01-02
last_seen_parent: 2025-11-26
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 189.4, "avg_administrations": 6}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 28 times with a 10.7 weekly interval (299.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Uveitis - ADALIMUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Uveitis - ADALIMUMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £9,086
first_seen: 2020-08-09
last_seen: 2024-05-31
first_seen_parent: 2018-06-07
last_seen_parent: 2025-07-28
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11 times with a 6.5 weekly interval (71.5 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 13 times with a 5.1 weekly interval (66.3 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 495.0, "avg_administrations": 29}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 408.0, "avg_administrations": 27}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Uveitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £16,494
first_seen: 2021-11-02
last_seen: 2025-12-03
first_seen_parent: 2020-03-27
last_seen_parent: 2025-08-03
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 487.2, "avg_administrations": 17}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11 times with a 11.7 weekly interval (128.7 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £17,737
first_seen: 2018-06-02
last_seen: 2025-03-26
first_seen_parent: 2020-04-04
last_seen_parent: 2024-01-31
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 350.5, "avg_administrations": 28}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 28 times with a 3.6 weekly interval (100.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD - RANIBIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD - RANIBIZUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £12,759
first_seen: 2019-07-09
last_seen: 2025-03-03
first_seen_parent: 2020-11-19
last_seen_parent: 2024-05-12
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RANIBIZUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 22 times with a 7.9 weekly interval (173.8 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 11 times with a 6.9 weekly interval (75.9 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 223.0, "avg_administrations": 5}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 277.3, "avg_administrations": 7}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £24,946
first_seen: 2021-07-06
last_seen: 2025-10-11
first_seen_parent: 2019-06-14
last_seen_parent: 2025-06-09
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 361.8, "avg_administrations": 17}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 22 times with a 6.8 weekly interval (149.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £19,097
first_seen: 2019-07-30
last_seen: 2025-01-05
first_seen_parent: 2019-09-19
last_seen_parent: 2025-04-26
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 291.6, "avg_administrations": 8}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 12 times with a 7.9 weekly interval (94.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £19,004
first_seen: 2019-09-10
last_seen: 2025-08-15
first_seen_parent: 2018-05-11
last_seen_parent: 2024-04-30
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 73.8, "avg_administrations": 21}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 30 times with a 11.7 weekly interval (351.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Atopic dermatitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £15,850
first_seen: 2019-01-28
last_seen: 2025-05-25
first_seen_parent: 2017-09-27
last_seen_parent: 2024-05-11
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 210.0, "avg_administrations": 29}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 14 times with a 7.1 weekly interval (99.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £20,248
first_seen: 2018-02-03
last_seen: 2024-07-29
first_seen_parent: 2018-11-29
last_seen_parent: 2024-12-31
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 384.8, "avg_administrations": 26}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 21 times with a 10.8 weekly interval (226.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - IBRUTINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - IBRUTINIB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £12,997
first_seen: 2020-06-14
last_seen: 2024-11-17
first_seen_parent: 2018-02-25
last_seen_parent: 2025-12-26
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: IBRUTINIB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 24 times with a 2.3 weekly interval (55.2 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 18 times with a 5.1 weekly interval (91.8 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 376.7, "avg_administrations": 24}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 422.4, "avg_administrations": 29}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - IBRUTINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - IBRUTINIB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £13,692
first_seen: 2019-06-05
last_seen: 2025-07-03
first_seen_parent: 2020-04-29
last_seen_parent: 2024-11-18
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: IBRUTINIB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 25 times with a 6.6 weekly interval (165.0 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 23 times with a 7.4 weekly interval (170.2 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 174.8, "avg_administrations": 23}, {"drug": "NATALIZUMAB", "avg_dose_mg": 486.4, "avg_administrations": 25}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £13,368
first_seen: 2021-08-11
last_seen: 2025-04-19
first_seen_parent: 2019-01-01
last_seen_parent: 2025-09-28
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 205.5, "avg_administrations": 25}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 19 times with a 3.7 weekly interval (70.3 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Colorectal cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £15,355
first_seen: 2020-05-25
last_seen: 2024-10-02
first_seen_parent: 2020-08-07
last_seen_parent: 2024-10-01
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 253.6, "avg_administrations": 5}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 19 times with a 10.0 weekly interval (190.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £3,911
first_seen: 2018-10-05
last_seen: 2024-12-26
first_seen_parent: 2019-06-15
last_seen_parent: 2025-08-17
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 325.3, "avg_administrations": 29}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 18 times with a 3.0 weekly interval (54.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £17,540
first_seen: 2020-01-10
last_seen: 2025-06-22
first_seen_parent: 2020-09-15
last_seen_parent: 2024-08-26
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 162.2, "avg_administrations": 28}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 24 times with a 5.2 weekly interval (124.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £5,966
first_seen: 2020-10-31
last_seen: 2024-07-29
first_seen_parent: 2018-03-17
last_seen_parent: 2024-02-26
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 156.1, "avg_administrations": 16}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 14 times with a 5.5 weekly interval (77.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £5,661
first_seen: 2018-12-25
last_seen: 2024-02-12
first_seen_parent: 2019-08-13
last_seen_parent: 2024-10-02
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 356.6, "avg_administrations": 9}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 21 times with a 3.1 weekly interval (65.1 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: LENALIDOMIDE
cost_pp_pa: £6,752
first_seen: 2020-03-25
last_seen: 2025-04-11
first_seen_parent: 2020-02-15
last_seen_parent: 2025-03-18
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: AFLIBERCEPT|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Diabetic macular oedema - AFLIBERCEPT - LENALIDOMIDE

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 5 times with a 5.6 weekly interval (28.0 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 20 times with a 10.8 weekly interval (216.0 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 251.8, "avg_administrations": 14}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 235.4, "avg_administrations": 12}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Diabetic macular oedema - AFLIBERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Diabetic macular oedema - AFLIBERCEPT - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £15,577
first_seen: 2019-01-21
last_seen: 2024-12-31
first_seen_parent: 2018-10-19
last_seen_parent: 2025-07-19
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: AFLIBERCEPT|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 15 times with a 8.6 weekly interval (129.0 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 28 times with a 2.5 weekly interval (70.0 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 314.9, "avg_administrations": 8}, {"drug": "NIVOLUMAB", "avg_dose_mg": 488.5, "avg_administrations": 30}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Diabetic macular oedema
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £10,811
first_seen: 2018-04-26
last_seen: 2025-05-08
first_seen_parent: 2018-12-28
last_seen_parent: 2025-04-17
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 174.3, "avg_administrations": 8}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 10 times with a 8.1 weekly interval (81.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Giant cell arteritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £19,946
first_seen: 2018-11-23
last_seen: 2025-10-17
first_seen_parent: 2018-03-21
last_seen_parent: 2025-11-21
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 218.2, "avg_administrations": 7}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 8 times with a 7.5 weekly interval (60.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HER2+ breast cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £14,394
first_seen: 2019-12-05
last_seen: 2024-07-17
first_seen_parent: 2017-03-05
last_seen_parent: 2025-06-10
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 151.8, "avg_administrations": 30}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 30 times with a 5.2 weekly interval (156.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Mantle cell lymphoma - IBRUTINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Mantle cell lymphoma - IBRUTINIB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £10,936
first_seen: 2021-06-01
last_seen: 2025-07-21
first_seen_parent: 2021-09-16
last_seen_parent: 2025-06-26
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: IBRUTINIB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 23 times with a 4.9 weekly interval (112.7 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 20 times with a 5.0 weekly interval (100.0 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 176.8, "avg_administrations": 20}, {"drug": "BARICITINIB", "avg_dose_mg": 94.4, "avg_administrations": 26}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Mantle cell lymphoma - IBRUTINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Mantle cell lymphoma - IBRUTINIB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £18,232
first_seen: 2020-03-24
last_seen: 2024-04-15
first_seen_parent: 2018-06-04
last_seen_parent: 2025-03-17
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: IBRUTINIB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 15 times with a 2.6 weekly interval (39.0 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 30 times with a 9.0 weekly interval (270.0 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 414.7, "avg_administrations": 28}, {"drug": "NIVOLUMAB", "avg_dose_mg": 427.1, "avg_administrations": 14}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Mantle cell lymphoma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £13,512
first_seen: 2018-01-13
last_seen: 2025-02-09
first_seen_parent: 2017-08-03
last_seen_parent: 2025-03-01
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 384.4, "avg_administrations": 19}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 29 times with a 9.6 weekly interval (278.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Melanoma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £6,278
first_seen: 2018-07-05
last_seen: 2024-08-01
first_seen_parent: 2017-09-11
last_seen_parent: 2025-06-15
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 235.5, "avg_administrations": 5}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 20 times with a 10.4 weekly interval (208.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £27,924
first_seen: 2021-08-24
last_seen: 2025-02-14
first_seen_parent: 2017-02-21
last_seen_parent: 2024-07-08
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 76.1, "avg_administrations": 24}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 7 times with a 11.1 weekly interval (77.7 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis - NATALIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis - NATALIZUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £5,113
first_seen: 2021-10-03
last_seen: 2024-03-07
first_seen_parent: 2021-09-19
last_seen_parent: 2024-12-07
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NATALIZUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 8 times with a 8.4 weekly interval (67.2 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 4 times with a 11.5 weekly interval (46.0 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 477.7, "avg_administrations": 23}, {"drug": "SECUKINUMAB", "avg_dose_mg": 396.7, "avg_administrations": 24}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis - NATALIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis - NATALIZUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £13,478
first_seen: 2020-12-16
last_seen: 2024-11-24
first_seen_parent: 2018-02-19
last_seen_parent: 2025-03-31
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NATALIZUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 24 times with a 4.0 weekly interval (96.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 24 times with a 4.5 weekly interval (108.0 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 484.9, "avg_administrations": 27}, {"drug": "RITUXIMAB", "avg_dose_mg": 134.9, "avg_administrations": 25}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £13,886
first_seen: 2018-03-25
last_seen: 2024-12-30
first_seen_parent: 2020-10-02
last_seen_parent: 2025-01-05
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 64.0, "avg_administrations": 4}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 26 times with a 8.7 weekly interval (226.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-Hodgkin lymphoma - RITUXIMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £4,733
first_seen: 2019-08-10
last_seen: 2025-06-14
first_seen_parent: 2021-07-11
last_seen_parent: 2024-01-06
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RITUXIMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 17 times with a 2.4 weekly interval (40.8 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 10 times with a 11.7 weekly interval (117.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 282.4, "avg_administrations": 5}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 92.8, "avg_administrations": 28}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-Hodgkin lymphoma - RITUXIMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £4,393
first_seen: 2020-04-10
last_seen: 2025-02-19
first_seen_parent: 2019-09-07
last_seen_parent: 2024-06-25
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RITUXIMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 23 times with a 2.3 weekly interval (52.9 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 28 times with a 5.7 weekly interval (159.6 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 144.3, "avg_administrations": 4}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 93.4, "avg_administrations": 21}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-Hodgkin lymphoma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £12,081
first_seen: 2019-06-22
last_seen: 2025-08-11
first_seen_parent: 2019-03-23
last_seen_parent: 2024-06-05
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 231.0, "avg_administrations": 30}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 18 times with a 10.6 weekly interval (190.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £23,537
first_seen: 2020-10-27
last_seen: 2024-07-10
first_seen_parent: 2017-09-13
last_seen_parent: 2024-04-11
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 84.7, "avg_administrations": 28}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 26 times with a 5.6 weekly interval (145.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £12,653
first_seen: 2020-04-05
last_seen: 2025-08-27
first_seen_parent: 2019-02-05
last_seen_parent: 2024-11-25
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 282.9, "avg_administrations": 29}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 7 times with a 9.8 weekly interval (68.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £4,395
first_seen: 2020-02-02
last_seen: 2024-07-03
first_seen_parent: 2017-04-05
last_seen_parent: 2025-12-27
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 184.1, "avg_administrations": 15}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 30 times with a 2.4 weekly interval (72.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - ADALIMUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - ADALIMUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £9,087
first_seen: 2022-10-21
last_seen: 2024-07-15
first_seen_parent: 2018-04-14
last_seen_parent: 2025-11-04
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 29 times with a 2.8 weekly interval (81.2 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 4 times with a 8.1 weekly interval (32.4 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 413.3, "avg_administrations": 14}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 271.0, "avg_administrations": 7}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - ADALIMUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - ADALIMUMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £13,279
first_seen: 2022-10-07
last_seen: 2025-10-31
first_seen_parent: 2019-08-20
last_seen_parent: 2025-10-24
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 26 times with a 9.5 weekly interval (247.0 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 19 times with a 11.9 weekly interval (226.1 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 108.8, "avg_administrations": 24}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 130.5, "avg_administrations": 9}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £5,960
first_seen: 2019-01-25
last_seen: 2025-11-17
first_seen_parent: 2017-01-15
last_seen_parent: 2025-06-01
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 179.0, "avg_administrations": 12}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 27 times with a 3.5 weekly interval (94.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £9,230
first_seen: 2019-12-15
last_seen: 2024-10-20
first_seen_parent: 2017-12-15
last_seen_parent: 2025-11-19
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 317.0, "avg_administrations": 7}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 10 times with a 6.7 weekly interval (67.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - USTEKINUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - USTEKINUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £3,056
first_seen: 2019-09-15
last_seen: 2024-12-15
first_seen_parent: 2020-11-17
last_seen_parent: 2024-10-21
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: USTEKINUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 4 times with a 6.5 weekly interval (26.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 23 times with a 7.3 weekly interval (167.9 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 214.7, "avg_administrations": 21}, {"drug": "ETANERCEPT", "avg_dose_mg": 424.7, "avg_administrations": 11}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - USTEKINUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - USTEKINUMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £5,922
first_seen: 2022-02-13
last_seen: 2024-04-26
first_seen_parent: 2021-11-27
last_seen_parent: 2024-07-23
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: USTEKINUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 18 times with a 7.1 weekly interval (127.8 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 7 times with a 10.7 weekly interval (74.9 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 433.9, "avg_administrations": 17}, {"drug": "ADALIMUMAB", "avg_dose_mg": 403.7, "avg_administrations": 14}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £7,200
first_seen: 2019-02-11
last_seen: 2025-03-25
first_seen_parent: 2019-08-15
last_seen_parent: 2025-05-16
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 217.6, "avg_administrations": 4}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 27 times with a 6.6 weekly interval (178.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £27,515
first_seen: 2019-05-10
last_seen: 2025-05-03
first_seen_parent: 2018-11-11
last_seen_parent: 2025-10-10
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 231.4, "avg_administrations": 4}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 6 times with a 9.8 weekly interval (58.8 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £22,644
first_seen: 2019-04-09
last_seen: 2025-05-14
first_seen_parent: 2017-12-23
last_seen_parent: 2025-06-27
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 97.8, "avg_administrations": 10}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 13 times with a 3.4 weekly interval (44.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Renal cell carcinoma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £8,907
first_seen: 2019-04-05
last_seen: 2025-10-04
first_seen_parent: 2020-12-06
last_seen_parent: 2025-06-28
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 423.2, "avg_administrations": 29}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 10 times with a 6.1 weekly interval (61.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £27,737
first_seen: 2018-04-06
last_seen: 2025-03-06
first_seen_parent: 2018-07-29
last_seen_parent: 2025-07-31
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 189.7, "avg_administrations": 28}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 5 times with a 10.9 weekly interval (54.5 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - ADALIMUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - ADALIMUMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £5,257
first_seen: 2019-01-26
last_seen: 2024-03-04
first_seen_parent: 2021-11-20
last_seen_parent: 2025-01-21
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9 times with a 3.3 weekly interval (29.7 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 24 times with a 7.3 weekly interval (175.2 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 464.8, "avg_administrations": 18}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 412.0, "avg_administrations": 6}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £6,675
first_seen: 2019-07-02
last_seen: 2024-06-13
first_seen_parent: 2020-01-08
last_seen_parent: 2024-08-30
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 114.7, "avg_administrations": 11}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 17 times with a 4.0 weekly interval (68.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £19,493
first_seen: 2020-02-01
last_seen: 2024-06-30
first_seen_parent: 2020-08-15
last_seen_parent: 2024-10-17
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 320.0, "avg_administrations": 24}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 10 times with a 11.4 weekly interval (114.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £18,162
first_seen: 2019-12-31
last_seen: 2025-09-22
first_seen_parent: 2017-05-27
last_seen_parent: 2024-10-22
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 78.0, "avg_administrations": 21}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 30 times with a 4.7 weekly interval (141.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £11,916
first_seen: 2018-09-24
last_seen: 2024-06-18
first_seen_parent: 2019-07-01
last_seen_parent: 2024-12-30
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 181.2, "avg_administrations": 22}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 6 times with a 10.6 weekly interval (63.6 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - VEDOLIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - VEDOLIZUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £8,875
first_seen: 2021-01-13
last_seen: 2025-08-24
first_seen_parent: 2021-11-02
last_seen_parent: 2025-03-01
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: VEDOLIZUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 25 times with a 10.8 weekly interval (270.0 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 30 times with a 9.3 weekly interval (279.0 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 483.3, "avg_administrations": 17}, {"drug": "NATALIZUMAB", "avg_dose_mg": 480.0, "avg_administrations": 8}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £8,682
first_seen: 2020-03-02
last_seen: 2025-05-11
first_seen_parent: 2018-04-10
last_seen_parent: 2024-02-18
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 423.2, "avg_administrations": 11}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 27 times with a 2.2 weekly interval (59.4 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - TOFACITINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - TOFACITINIB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £9,351
first_seen: 2020-05-17
last_seen: 2025-09-03
first_seen_parent: 2020-12-06
last_seen_parent: 2025-05-23
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TOFACITINIB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 22 times with a 2.9 weekly interval (63.8 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 11 times with a 2.2 weekly interval (24.2 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 467.5, "avg_administrations": 8}, {"drug": "IBRUTINIB", "avg_dose_mg": 240.3, "avg_administrations": 21}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £6,293
first_seen: 2021-02-14
last_seen: 2024-12-04
first_seen_parent: 2017-09-19
last_seen_parent: 2025-10-20
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 159.7, "avg_administrations": 20}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 12 times with a 3.0 weekly interval (36.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Uveitis - ADALIMUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Uveitis - ADALIMUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £13,074
first_seen: 2022-10-29
last_seen: 2025-08-19
first_seen_parent: 2018-02-22
last_seen_parent: 2025-12-23
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 20 times with a 3.4 weekly interval (68.0 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 25 times with a 11.9 weekly interval (297.5 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 369.6, "avg_administrations": 11}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 346.9, "avg_administrations": 28}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Uveitis - ADALIMUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Uveitis - ADALIMUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £19,078
first_seen: 2022-12-02
last_seen: 2024-01-30
first_seen_parent: 2021-02-28
last_seen_parent: 2025-04-14
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 29 times with a 7.0 weekly interval (203.0 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 4 times with a 7.2 weekly interval (28.8 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 403.3, "avg_administrations": 23}, {"drug": "NATALIZUMAB", "avg_dose_mg": 336.5, "avg_administrations": 11}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Uveitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £12,473
first_seen: 2021-12-14
last_seen: 2024-05-17
first_seen_parent: 2020-06-28
last_seen_parent: 2025-09-20
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 422.2, "avg_administrations": 25}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8 times with a 7.4 weekly interval (59.2 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £4,905
first_seen: 2021-01-07
last_seen: 2024-05-10
first_seen_parent: 2019-12-22
last_seen_parent: 2025-12-06
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 470.6, "avg_administrations": 5}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 23 times with a 10.0 weekly interval (230.0 weeks total treatment length)


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - RANIBIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - RANIBIZUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £15,281
first_seen: 2022-01-05
last_seen: 2024-02-15
first_seen_parent: 2019-12-22
last_seen_parent: 2024-08-11
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RANIBIZUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 29 times with a 9.5 weekly interval (275.5 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 5 times with a 7.3 weekly interval (36.5 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 94.8, "avg_administrations": 26}, {"drug": "ETANERCEPT", "avg_dose_mg": 162.3, "avg_administrations": 22}]


